<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">13023</article-id><article-id pub-id-type="doi">10.7554/eLife.13023</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>PI(3,5)P<sub>2</sub> biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-46587"><name><surname>Mironova</surname><given-names>Yevgeniya A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46588"><name><surname>Lenk</surname><given-names>Guy M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46589"><name><surname>Lin</surname><given-names>Jing-Ping</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46599"><name><surname>Lee</surname><given-names>Seung Joon</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16739"><name><surname>Twiss</surname><given-names>Jeffery L</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46595"><name><surname>Vaccari</surname><given-names>Ilaria</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46596"><name><surname>Bolino</surname><given-names>Alessandra</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46598"><name><surname>Havton</surname><given-names>Leif A</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46592"><name><surname>Min</surname><given-names>Sang H</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46593"><name><surname>Abrams</surname><given-names>Charles S</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46600"><name><surname>Shrager</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46601"><name><surname>Meisler</surname><given-names>Miriam H</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-49468"><name><surname>Giger</surname><given-names>Roman J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2926-3336</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="con13"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Cell and Developmental Biology</institution>, <institution>University of Michigan School of Medicine</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Cellular and Molecular Biology Graduate Program</institution>, <institution>University of Michigan School of Medicine</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Human Genetics</institution>, <institution>University of Michigan School of Medicine</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Biological Sciences</institution>, <institution>University of South Carolina</institution>, <addr-line><named-content content-type="city">Columbia</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Human Inherited Neuropathies Unit</institution>, <institution>INSPE-Institute for Experimental Neurology, San Raffaele Scientific Institute</institution>, <addr-line><named-content content-type="city">Milan</named-content></addr-line>, <country>Italy</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Department of Neurology</institution>, <institution>David Geffen School of Medicine at UCLA</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">Department of Medicine</institution>, <institution>University of Pennsylvania School of Medicine</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><label>8</label><institution content-type="dept">Department of Neurobiology and Anatomy</institution>, <institution>University of Rochester Medical Center</institution>, <addr-line><named-content content-type="city">Rochester</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><label>9</label><institution content-type="dept">Department of Neurology</institution>, <institution>University of Michigan School of Medicine</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Barres</surname><given-names>Ben</given-names></name><aff id="aff10"><institution>Stanford School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>rgiger@med.umich.edu</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>03</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>5</volume><elocation-id>e13023</elocation-id><history><date date-type="received"><day>13</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>23</day><month>03</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Mironova et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Mironova et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-13023-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.13023.001</object-id><p>Proper development of the CNS axon-glia unit requires bi-directional communication between axons and oligodendrocytes (OLs). We show that the signaling lipid phosphatidylinositol-3,5-bisphosphate [PI(3,5)P<sub>2</sub>] is required in neurons and in OLs for normal CNS myelination. In mice, mutations of <italic>Fig4, Pikfyve</italic> or <italic>Vac14,</italic> encoding key components of the PI(3,5)P<sub>2</sub> biosynthetic complex, each lead to impaired OL maturation, severe CNS hypomyelination and delayed propagation of compound action potentials. Primary OLs deficient in <italic>Fig4</italic> accumulate large LAMP1<sup>+</sup> and Rab7<sup>+</sup> vesicular structures and exhibit reduced membrane sheet expansion. PI(3,5)P<sub>2</sub> deficiency leads to accumulation of myelin-associated glycoprotein (MAG) in LAMP1<sup>+</sup>perinuclear vesicles that fail to migrate to the nascent myelin sheet. Live-cell imaging of OLs after genetic or pharmacological inhibition of PI(3,5)P<sub>2</sub> synthesis revealed impaired trafficking of plasma membrane-derived MAG through the endolysosomal system in primary cells and brain tissue. Collectively, our studies identify PI(3,5)P<sub>2</sub> as a key regulator of myelin membrane trafficking and myelinogenesis.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.001">http://dx.doi.org/10.7554/eLife.13023.001</ext-link></p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.13023.002</object-id><title>eLife digest</title><p>Neurons communicate with each other through long cable-like extensions called axons. An insulating sheath called myelin (or white matter) surrounds each axon, and allows electrical impulses to travel more quickly. Cells in the brain called oligodendrocytes produce myelin. If the myelin sheath is not properly formed during development, or is damaged by injury or disease, the consequences can include paralysis, impaired thought, and loss of vision.</p><p>Oligodendrocytes have complex shapes, and each can generate myelin for as many as 50 axons. Oligodendrocytes produce the building blocks of myelin inside their cell bodies, by following instructions encoded by genes within the nucleus. However, the signals that regulate the trafficking of these components to the myelin sheath are poorly understood.</p><p>Mironova et al. set out to determine whether signaling molecules called phosphoinositides help oligodendrocytes to mature and move myelin building blocks from the cell bodies to remote contact points with axons. Genetic techniques were used to manipulate an enzyme complex in mice that controls the production and turnover of a phosphoinositide called PI(3,5)P<sub>2</sub>. Mironova et al. found that reducing the levels of PI(3,5)P<sub>2</sub> in oligodendrocytes caused the trafficking of certain myelin building blocks to stall. Key myelin components instead accumulated inside bubble-like structures near the oligodendrocyte’s cell body. This showed that PI(3,5)P<sub>2</sub> in oligodendrocytes is essential for generating myelin. Further experiments then revealed that reducing PI(3,5)P<sub>2</sub> in the neurons themselves indirectly prevented the oligodendrocytes from maturing. This suggests that PI(3,5)P<sub>2</sub> also takes part in communication between axons and oligodendrocytes during development of the myelin sheath.</p><p>A key next step will be to identify the regulatory mechanisms that control the production of PI(3,5)P<sub>2</sub> in oligodendrocytes and neurons. Future studies could also explore what PI(3,5)P<sub>2</sub> acts upon inside the axons, and which signaling molecules support the maturation of oligodendrocytes. Finally, it remains unclear whether PI(3,5)P<sub>2</sub>signaling is also required for stabilizing mature myelin, and for repairing myelin after injury in the adult brain. Further work could therefore address these questions as well.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.002">http://dx.doi.org/10.7554/eLife.13023.002</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author Keywords</title><kwd>oligodendrocytes</kwd><kwd>optic nerve</kwd><kwd>axo-glial interaction</kwd><kwd>membrane transport</kwd><kwd>lysosome</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research Organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000071</institution-id><institution>National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>T32HD007505</award-id><principal-award-recipient><name><surname>Mironova</surname><given-names>Yevgeniya A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>T32GM007315</award-id><principal-award-recipient><name><surname>Mironova</surname><given-names>Yevgeniya A</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005984</institution-id><institution>Dr. Miriam and Sheldon G. Adelson Medical Research Foundation</institution></institution-wrap></funding-source><award-id>APNRR</award-id><principal-award-recipient><name><surname>Twiss</surname><given-names>Jeffery L</given-names></name><name><surname>Havton</surname><given-names>Leif A</given-names></name><name><surname>Giger</surname><given-names>Roman J</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>HL040387</award-id><principal-award-recipient><name><surname>Abrams</surname><given-names>Charles S</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>HL120846</award-id><principal-award-recipient><name><surname>Abrams</surname><given-names>Charles S</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS081281</award-id><principal-award-recipient><name><surname>Shrager</surname><given-names>Peter</given-names></name><name><surname>Meisler</surname><given-names>Miriam H</given-names></name><name><surname>Giger</surname><given-names>Roman J</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Schmitt Program on Integrative Brain Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Shrager</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01GM24872</award-id><principal-award-recipient><name><surname>Meisler</surname><given-names>Miriam H</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.5</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The signaling lipid PI(3,5)P<sub>2</sub> supports the formation of the myelin sheath, by regulating trafficking of myelin building blocks within oligodendrocytes and communication between oligodendrocytes and neuronal axons.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>In the vertebrate CNS, the majority of long axons are myelinated. Myelin greatly increases the conduction velocity of action potentials and provides metabolic support for axons. Bidirectional axo-glial signaling is critical for nervous system myelination and fiber stability (<xref ref-type="bibr" rid="bib47">Nave and Trapp, 2008</xref>; <xref ref-type="bibr" rid="bib62">Simons and Lyons, 2013</xref>). Myelin development is regulated by oligodendrocyte (OL) intrinsic mechanisms (<xref ref-type="bibr" rid="bib79">Zuchero and Barres, 2013</xref>), astrocyte secreted factors (<xref ref-type="bibr" rid="bib31">Ishibashi et al., 2006</xref>), neuronal electrical activity (<xref ref-type="bibr" rid="bib2">Barres and Raff, 1993</xref>; <xref ref-type="bibr" rid="bib31">Ishibashi et al., 2006</xref>) and axon derived chemical signals (<xref ref-type="bibr" rid="bib13">Coman et al., 2005</xref>; <xref ref-type="bibr" rid="bib49">Ohno et al., 2009</xref>; <xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>, <xref ref-type="bibr" rid="bib73">Yao et al., 2014</xref>).</p><p>Disorders associated with defective CNS white matter range from multiple sclerosis and inherited leukodystrophies to psychiatric disorders (<xref ref-type="bibr" rid="bib23">Fields, 2008</xref>; <xref ref-type="bibr" rid="bib40">Makinodan et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Perlman and Mar, 2012</xref>).</p><p>FIG4 is an evolutionarily conserved lipid phosphatase that removes the 5’ phosphate group from phosphatidylinositol(3,5)bisphosphate [PI(3,5)P<sub>2</sub>] to produce PI(3)P. Together with its antagonistic kinase PIKFYVE and the scaffold protein VAC14, FIG4 forms an enzyme complex that regulates the interconversion of PI(3)P and PI(3,5)P<sub>2</sub> on membranes of the late endosomal/ lysosomal (LE/Lys) compartment (<xref ref-type="bibr" rid="bib34">Jin et al., 2008</xref>; <xref ref-type="bibr" rid="bib44">McCartney et al., 2014</xref>). In addition to its 5’-phosphatase activity, Fig4 is required to stabilize the enzyme complex. PI(3,5)P<sub>2</sub> directly regulates the lysosomal cation channels TRPML1, TPC1 and TPC2 (<xref ref-type="bibr" rid="bib15">Dong et al., 2010</xref>; <xref ref-type="bibr" rid="bib67">Wang et al., 2012</xref>; <xref ref-type="bibr" rid="bib68">2014</xref>). Reduced activity of these lysosomal channels and the resulting osmotic enlargement of the LE/Lys may underlie vacuolization in <italic>Fig4</italic> null cells (<xref ref-type="bibr" rid="bib38">Lenk and Meisler, 2014</xref>). Consistent with this model, overexpression of TRPML1 in <italic>Vac14</italic> and <italic>Fig4</italic> mutant cells appears to rescue vacuolization (<xref ref-type="bibr" rid="bib15">Dong et al., 2010</xref>; <xref ref-type="bibr" rid="bib78">Zou et al., 2015</xref>). In <italic>Drosophila</italic>, loss of TRPML1 generates a muscle vacuolization phenotype reminiscent of FIG4 deficiency (<xref ref-type="bibr" rid="bib6">Bharadwaj et al., 2016</xref>).</p><p>FIG4 deficiency is particularly harmful for neural cells with elaborate morphologies, including projection neurons and myelinating glia. Mutations of human <italic>FIG4</italic> result in neurological disorders including Charcot-Marie-Tooth type 4J, a severe form of peripheral neuropathy (<xref ref-type="bibr" rid="bib12">Chow et al., 2007</xref>; <xref ref-type="bibr" rid="bib48">Nicholson et al., 2011</xref>), polymicrogyria with epilepsy (<xref ref-type="bibr" rid="bib3">Baulac et al., 2014</xref>), and Yunis-Varon syndrome (<xref ref-type="bibr" rid="bib9">Campeau et al., 2013</xref>). Mice null for <italic>Fig4</italic> exhibit severe tremor, brain region-specific spongiform degeneration, hypomyelination, and juvenile lethality (<xref ref-type="bibr" rid="bib12">Chow et al., 2007</xref>; <xref ref-type="bibr" rid="bib21">Ferguson et al., 2009</xref>; <xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>). We previously demonstrated that a <italic>Fig4</italic> transgene driven by the neuron-specific enolase (<italic>NSE</italic>) promoter rescued juvenile lethality and neurodegeneration in global <italic>Fig4</italic> null mice, and that these phenotypes were not rescued by an astrocyte-specific <italic>Fig4</italic> transgene (<xref ref-type="bibr" rid="bib22">Ferguson et al., 2012</xref>). The neuron-specific transgene also rescued conduction in peripheral nerves <xref ref-type="bibr" rid="bib22">(Ferguson et al., 2012</xref>) and structural defects in CNS myelination (<xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>). Conversely, inactivation of <italic>Fig4</italic> specifically in neurons resulted in region-specific neurodegeneration (<xref ref-type="bibr" rid="bib22">Ferguson et al., 2012</xref>).</p><p>The cellular and molecular mechanisms relating loss of <italic>Fig4</italic> to hypomyelination are poorly understood. To further characterize the requirement of PI(3,5)P<sub>2</sub> for CNS myelination, we manipulated individual components of the PI(3,5)P<sub>2</sub> biosynthetic complex. <italic>Pikfyve</italic> and <italic>Vac14</italic> global null mice die prematurely, before the onset of CNS myelination (<xref ref-type="bibr" rid="bib76">Zhang et al., 2007</xref>; <xref ref-type="bibr" rid="bib29">Ikonomov et al., 2011</xref>). To circumvent this limitation, we employed a combination of conditional null alleles and hypomorphic alleles in the mouse. Our study shows that multiple strategies to perturb the FIG4/PIKFYVE/VAC14 enzyme complex, and by extension the lipid product PI(3,5)P<sub>2</sub>, result in the common endpoints of arrested OL differentiation, impaired myelin protein trafficking through the LE/Lys compartment, and severe CNS hypomyelination. We demonstrate that these defects in myelin biogenesis are functionally relevant and result in faulty conduction of electrical impulses.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Conditional ablation of <italic>Fig4</italic> in neurons or the OL lineage results in CNS hypomyelination</title><p>In the early postnatal brain, <italic>Fig4</italic> is broadly expressed and enriched in oligodendrocyte progenitor cells (OPCs) and newly formed OLs (NFOs) (<xref ref-type="bibr" rid="bib77">Zhang et al., 2014</xref>). Mice in which exon 4 of the <italic>Fig4</italic> gene is flanked by <italic>loxP</italic> sites (<xref ref-type="bibr" rid="bib22">Ferguson et al., 2012</xref>) were used to generate <italic>Fig4<sup>-/flox</sup>,SynCre</italic> and <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice deficient for <italic>Fig4</italic> in neurons or OLs, respectively. Myelin development in these conditional mutants, as well as the <italic>Fig4</italic> global mutant (<italic>Fig4<sup>-/-</sup></italic>) and control mice (<italic>Fig4<sup>+/+</sup></italic> and <italic>Fig4<sup>flox/+</sup></italic>), was analyzed by Fluoromyelin Green labeling (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In control brains, the corpus callosum and internal capsule were prominently labeled (<xref ref-type="fig" rid="fig1">Figure 1A and A’</xref>). Staining of these structures was weaker in <italic>Fig4<sup>-/flox</sup>,SynCre</italic> brains and further reduced in <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> and <italic>Fig4<sup>-/-</sup></italic> brains (<xref ref-type="fig" rid="fig1">Figure 1B-D’</xref>). For a quantitative comparison of the myelination defects, whole brain membranes were prepared from P21 pups and analyzed by immunoblotting with antibodies specific for the myelin markers myelin-associated glycoprotein (MAG), 2’,3’-cyclic-nucleotide 3’-phosphodiesterase (CNPase), proteolipid protein (PLP), and myelin basic protein (MBP) (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Compared to <italic>Fig4<sup>+/+</sup> </italic>membranes, a significant reduction in myelin proteins was evident in <italic>Fig4<sup>-/-</sup></italic> mice, <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice and <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice (<xref ref-type="fig" rid="fig1">Figure 1F -I</xref>). The finding that the neuronal marker classIII <italic>β</italic>-tubulin is not significantly decreased in any of these mice indicates that the decrease in CNS myelin is not secondary to neuronal loss. While the <italic>Olig2</italic> promoter is highly active in the OL lineage, activity has also been reported in astrocytes and a subset of neurons (<xref ref-type="bibr" rid="bib14">Dessaud et al., 2007</xref>; <xref ref-type="bibr" rid="bib77">Zhang et al., 2014</xref>). To independently assess the role of <italic>Fig4</italic> in the OL lineage, we generated <italic>Fig4<sup>-/flox</sup>,PdgfraCreER</italic> mice that permit tamoxifen inducible gene ablation. At postnatal-days (P)5 and 6, before the onset of CNS myelination, <italic>Fig4<sup>-/flox</sup>,PdgfraCreER</italic> pups were injected with 4-hydroxytamoxifen and brains were analyzed at P20-P21. Inducible ablation of <italic>Fig4</italic> in the OL-linage resulted in reduced expression of the myelin proteins CNPase, MAG, and MBP, as assessed by Western blot analysis (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–B’</xref>) as well as myelin loss in forebrain structures and cerebellar white matter (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C–D’</xref>). Fewer <italic>Plp1<sup>+</sup></italic> OLs were present in optic nerve sections of <italic>Fig4<sup>-/flox</sup>,PdgfraCreER</italic> mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E and E’</xref>). Together, these studies indicate that proper CNS myelination is dependent upon OL cell-autonomous (intrinsic) functions of <italic>Fig4,</italic> in addition to non-OL-autonomous (extrinsic) functions of <italic>Fig4</italic> provided by neurons.<fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.13023.003</object-id><label>Figure 1.</label><caption><title>Conditional ablation of <italic>Fig4</italic> in neurons or OLs leads to CNS hypomyelination.</title><p>(<bold>A-D</bold>) Coronal sections of juvenile (P21-30) mouse forebrain stained with FluoroMyelin Green. (<bold>A</bold>) <italic>Fig4</italic> control mice (harboring at least one <italic>Fig4</italic> WT allele), (<bold>B</bold>) <italic>Fig4</italic> germline null mice (<italic>Fig4<sup>-/-</sup>)</italic>, (<bold>C</bold>) <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice and (<bold>D</bold>) <italic>Fig4<sup>-flox</sup>,Olig2Cre</italic> mice. Thinning of the corpus callosum and internal capsule (white arrowheads) is observed in <italic>Fig4<sup>-/-</sup>, Fig4<sup>-/flox</sup>,SynCre,</italic> and <italic>Fig4<sup>-flox</sup>,Olig2Cre</italic> mice. (<bold>A’-D’</bold>) Higher magnification images of the corpus callosum. Scale bar (<bold>A-D</bold>), 1 mm and (<bold>A’-D’</bold>), 400 µm. (<bold>E</bold>) Representative Western blots of P21 brain membranes prepared from <italic>Fig4<sup>+/+</sup> </italic>(WT), <italic>Fig4<sup>-/-</sup>, Fig4<sup>-/flox</sup>,SynCre</italic> and <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice probed with antibodies specific for the myelin proteins MAG, CNPase, PLP, and MBP. To control for protein loading, membranes were probed for the neuronal marker class III β-tubulin (βIII Tub). (<bold>F-I</bold>) Quantification of Western blot signals for MAG, MBP, CNPase, and PLP in <italic>Fig4<sup>+/+</sup></italic> (black bars), <italic>Fig4<sup>-/-</sup></italic> (purple bars), <italic>Fig4<sup>-/flox</sup>,SynCre</italic> (light blue bars), and <italic>Fig4<sup>-flox</sup>,Olig2Cre</italic> (red bars) brain membranes. Quantification of myelin protein signals is normalized to βIII Tub. Relative protein intensities compared to WT brain are shown as mean value ± SEM. For each of the four genotypes, three independent membrane preparations were carried out. One-way ANOVA with multiple comparisons, Dunnett posthoc test; **p&lt;0.01, ***p&lt;0.001 and ****p&lt;0.0001. An independent strategy for OL-specific <italic>Fig4</italic> deletion results in a similar phenotype as shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. Histochemical staining of brain, spinal cord and dorsal root ganglion tissue sections of <italic>Fig4</italic> conditional knock-out mice, as well as Kaplan-Meier plots for <italic>Fig4<sup>-/flox</sup>,SynCre</italic> and <italic>Fig4<sup>-flox</sup>,Olig2Cre</italic> mice are shown in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.003">http://dx.doi.org/10.7554/eLife.13023.003</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13023-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>CNS hypomyelination in <italic>Fig4<sup>-/flox</sup>,PdgfrαCreER</italic> mice.</title><p>Representative Western blots of (<bold>A</bold>) P21 forebrain and (<bold>B</bold>) P21 hindbrain (cerebellum/brainstem) lysates prepared from <italic>Fig4</italic> control littermate mice (<italic>Fig4<sup>+/flox</sup>,PdgfrαCre-ER)</italic> and <italic>Fig4<sup>-/flox</sup>,PdgfrαCreER</italic> mutant mice, probed with antibodies specific for the myelin proteins MAG, CNPase and MBP. To control for protein loading, blots were probed for the neuronal marker class III β-tubulin (βIII Tub). (<bold>A’ </bold>and <bold>B’</bold>) Quantification of Western blot signals for MAG, CNPase and MBP in (<bold>A’</bold>) forebrain and (<bold>B’</bold>) cerebellum/brainstem lysates. Relative protein intensities compared to control tissue are shown as mean value ± SEM. Six pairs of control littermate and <italic>Fig4<sup>-/flox</sup>,PdgfrαCreER</italic> mice were analyzed and quantified. Unpaired Student’s <italic>t</italic>-test, *p=0.0323 (<bold>A</bold>', MAG), ***p=0.0006 (<bold>A</bold>', CNPase), **p=0.0096 (<bold>A’</bold>, MBP), **p=0.027 (B', MAG), **p=0.038 (<bold>B’,</bold> CNPase), ***p=0.0004 (<bold>B’</bold>, MBP). (<bold>C</bold> and <bold>C’</bold>) Sagittal sections of P21 forebrain of control littermate <italic>(Fig4<sup>+/flox</sup>,PdgfrαCreER)</italic> and <italic>Fig4<sup>-/flox</sup>,PdgfrαCreER</italic> mutant mice probed for <italic>Mbp</italic> mRNA expression. (<bold>D</bold> and <bold>D’</bold>) Sagittal sections of P21 cerebellum of control littermate <italic>(Fig4<sup>+/flox</sup>,PdgfrαCreER)</italic> and <italic>Fig4<sup>-/flox</sup>,PdgfrαCreER</italic> mutant mice probed for <italic>Mbp</italic> mRNA expression. (<bold>E</bold> and <bold>E’</bold>) Longitudinal optic nerve sections of P21 littermate control and <italic>Fig4<sup>-/flox</sup>,PdgfraCreER</italic> mice probed for <italic>Plp1</italic> mRNA expression. Scale bar (<bold>C-D’</bold>), 500 μm and (<bold>E</bold> and <bold>E’</bold>), 200 μm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.004">http://dx.doi.org/10.7554/eLife.13023.004</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig1-figsupp1-v2"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Loss of <italic>Fig4</italic> in the OL-lineage or neurons differentially affects spongiform degeneration and lifespan.</title><p>(<bold>A-D’’’</bold>) Hematoxylin/eosin stained tissue sections of P30 mouse neocortex, cerebellum, dorsal root ganglion (DRG) and spinal cord ventral horn. Tissue sections of mice with the following genotypes are shown: (<bold>A</bold>, <bold>B</bold>, <bold>C</bold>, <bold>D</bold>) control mice (<italic>Fig4<sup>flox/-</sup></italic>), (<bold>A’</bold>, <bold>B’</bold>, <bold>C’</bold>, <bold>D’</bold>) <italic>Fig4</italic> germline null mice (<italic>Fig4<sup>-/-</sup></italic>), (<bold>A”</bold>, <bold>B”</bold>, <bold>C”</bold>, <bold>D”</bold>)<italic>Fig4<sup>-/flox</sup>,SynCre</italic> conditional mutants and (<bold>A’’’</bold>, <bold>B’’’</bold>, <bold>C’’’</bold>, <bold>D’’’</bold>) <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> conditional mutants. Most notable are the large vacuolar (sponge-like) structures in different regions of the <italic>Fig4<sup>-/-</sup></italic> nervous system, including (<bold>A’</bold>) deep layers of the neocortex, (<bold>B’</bold>) deep cerebellar nuclei, (<bold>C’</bold>) DRGs and (<bold>D’</bold>) ventral horn of the spinal cord. (<bold>A”-D”</bold>) A milder but similar phenotype is observed in <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice. (<bold>A’’’</bold>) In the <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> neocortex small vacuoles are observed in all layers of the neocortex. (<bold>B’’’</bold> and <bold>C’’’</bold>) In <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice deep cerebellar nuclei and DRGs look largely normal. (<bold>D’’’</bold>) The large vacuoles in the spinal cord ventral horn of <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice likely represent motoneurons, as the <italic>Olig2</italic> promoter is known to drive cre expression in motoneurons and the OL-linage. (<bold>E</bold>) The <italic>Hb9-cre</italic> driver line was used for conditional deletion of <italic>Fig4</italic> specifically in motoneurons. Toluidine blue stained section of <italic>Fig4<sup>-/flox</sup>,Hb9Cre</italic> ventral horn shows multiple large vacuolar structures within the gray and white matter of the spinal cord. Examples of vacuolar structures are labeled with asterisks. Apparently normal motoneuron profiles are indicated by arrows. (<bold>F</bold>) Electron micrograph of <italic>Fig4<sup>-/flox</sup>,Hb9Cre</italic> ventral horn with large vacuolar structures labeled by asterisks. Vacuolar structures are mostly devoid of electron-dense material and found in axons surrounded by thin myelin sheaths (arrows). Vacuoles cause peripheral displacement of axoplasm and mitochondria. The arrowhead points to a dystrophic axon with accumulation of numerous smaller vesicles. (<bold>G</bold>) Viability of <italic>Fig4</italic> conditional mutants. Kaplan-Meier plot shows an average life-span of 6 months for <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice (n = 15), while <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice (n = 5) are viable for 12–14 months (the oldest mice currently in our colony).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.005">http://dx.doi.org/10.7554/eLife.13023.005</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig1-figsupp2-v2"/></fig></fig-group></p><p>As previously described, <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice exhibit impaired movement and region-specific vacuolization and neurodegeneration (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A”,B”,C”,D”</xref>) (<xref ref-type="bibr" rid="bib22">Ferguson et al., 2012</xref>). In contrast, <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice exhibit very mild vacuolization in brain (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A’’’,B’’’,C’’’,D’’’</xref>). Consistent with the known expression of the <italic>Olig2</italic> promoter in motor neurons (<xref ref-type="bibr" rid="bib45">Mizuguchi et al., 2001</xref>) ventral spinal cord of <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice shows extensive vacuolization (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D’’’</xref>), similar to <italic>Fig4<sup>-/flox</sup>, Mnx1Cre</italic> (otherwise referred to as <italic>Fig4<sup>-/flox</sup>,Hb9Cre</italic>) mice (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E</xref>) (<xref ref-type="bibr" rid="bib66">Vaccari et al., 2015</xref>). Analysis of <italic>Fig4<sup>-/flox</sup>,Hb9Cre</italic> spinal cord identified enlarged vacuoles within motoneuron axons, greatly extending their diameter and pushing the axoplasm into a thin peripheral rim near the plasma membrane (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2F</xref>). In contrast to the movement disability and reduced survival of <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice,(<xref ref-type="bibr" rid="bib22">Ferguson et al., 2012</xref>) the movement of <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice is normal and no premature death was observed, with the oldest now surviving beyond 14 months of age (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2G</xref>). There are no obvious defects in mobility of littermate controls and <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> conditional mutant mice at P23, as demonstrated in the <xref ref-type="other" rid="media1">Videos 1</xref> and <xref ref-type="other" rid="media2">2</xref>.<media content-type="glencoe play-in-place height-250 width-310" id="media1" mime-subtype="mp4" mimetype="video" xlink:href="elife-13023-media1.mp4"><object-id pub-id-type="doi">10.7554/eLife.13023.006</object-id><label>Video 1.</label><caption><title>Normal locomotion of juvenile <italic>Fig4<sup>+/flox</sup>,Olig2Cre</italic> mice.</title><p>A representative video of a control <italic>Fig4<sup>+/flox</sup>,Olig2Cre</italic> mouse at P23. N = 10</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.006">http://dx.doi.org/10.7554/eLife.13023.006</ext-link></p></caption></media><media content-type="glencoe play-in-place height-250 width-310" id="media2" mime-subtype="mp4" mimetype="video" xlink:href="elife-13023-media2.mp4"><object-id pub-id-type="doi">10.7554/eLife.13023.007</object-id><label>Video 2.</label><caption><title>Normal locomotion of juvenile <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice.</title><p>A representative video of a <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> conditional mutant mouse at P23 shows no obvious pathology in locomotion. N = 10</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.007">http://dx.doi.org/10.7554/eLife.13023.007</ext-link></p></caption></media></p></sec><sec id="s2-2"><title><italic>Fig4</italic> deficiency in neurons or OLs leads to developmental dysmyelination of the optic nerve</title><p>Analysis of P21 retina revealed the presence of numerous vacuoles in the inner retina of <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice but no defects in overall morphology or stratification (<xref ref-type="fig" rid="fig2">Figure 2A’</xref>). No vacuoles were detected in the <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> retina (<xref ref-type="fig" rid="fig2">Figure 2A’’</xref>). For ultrastructural analysis, optic nerves of <italic>Fig4</italic> conditional knock-out mice were processed for transmission electron microscopy (TEM). In P21 <italic>Fig4</italic> control mice (retaining at least one intact allele of <italic>Fig4</italic>), the fraction of myelinated axons in the optic nerve is 79± 2%. In optic nerves of <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice, only 9± 3% of axons are myelinated and in <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice only 12± 1% of axons are myelinated (<xref ref-type="fig" rid="fig2">Figure 2B–B’’ and D</xref>). To assess myelin health, we determined the g-ratio (the ratio of the inner axonal diameter to the total fiber diameter) of myelinated axons in the optic nerve of <italic>Fig4</italic> control and conditional mutants. Compared to control mice, a small but significant increase in g-ratio was observed in <italic>Fig4<sup>-/flox</sup>,SynCre</italic> and <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice, an indication of myelin thinning (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). To determine whether the optic nerve hypomyelination at P21 reflects a transient delay in myelin development, rather than a lasting defect, we repeated the analysis with adult mice. Similar to P21 optic nerves, ultrastructural analysis of both types of adult optic nerves revealed profound hypomyelination (<xref ref-type="fig" rid="fig2">Figure 2C–C’’</xref>). At P60-75, 92± 2% of axons are myelinated in <italic>Fig4</italic> control nerves. This is reduced to 16± 4% in <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice and 12± 2% in <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). It is noteworthy that conditional ablation of <italic>Fig4</italic> either in neurons or OLs leads to preferential absence of myelin sheaths on small and intermediate caliber axons, while many large caliber axons undergo myelination (<xref ref-type="fig" rid="fig2">Figure 2B’,B”,C’ and C”</xref>).<fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.13023.008</object-id><label>Figure 2.</label><caption><title>Conditional ablation of <italic>Fig4</italic> in neurons or in OLs leads to severe dysmyelination of the optic nerve.</title><p>(<bold>A-A’’</bold>) Sagittal sections of juvenile (P21) mouse retina embedded in epoxy resin and stained with toluidine blue. (<bold>A</bold>) <italic>Fig4</italic> control mice, harboring at least one <italic>Fig4</italic> WT allele, (<bold>A’</bold>) <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice and (<bold>A’’</bold>) <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice. Scale bar, 100 µm. (<bold>B-B’’</bold>) Representative TEM images of optic nerve cross sections of P21 (<bold>B</bold>) <italic>Fig4</italic> control, (<bold>B’</bold>) <italic>Fig4<sup>-/flox</sup>,SynCre</italic> and (<bold>B’’</bold>) <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice. (<bold>C-C’’</bold>) Representative TEM images of optic nerve cross sections of adult (P60-75) mice. (<bold>C</bold>) <italic>Fig4</italic> control, (<bold>C’</bold>) <italic>Fig4<sup>-/flox</sup>,SynCre</italic> and (<bold>C’’</bold>) <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice. Black arrows in <bold>C’</bold> indicate the presence of dystrophic axons. Scale bar (<bold>B-C’’</bold>) = 1 μm. (<bold>D</bold>) Quantification of percentage of myelinated fibers in the optic nerve at P21 and P60-75. At P21, <italic>Fig4</italic> controls (n = 3 mice, 3 nerves); <italic>Fig4<sup>-/flox</sup>,SynCre</italic> (n = 2 mice, 3 nerves) and <italic>Fig4<sup>-/flox</sup>,Olig2Cr</italic>e (n = 3 mice, 3 nerves). (<bold>E</bold>) Quantification of myelinated fiber g-ratios in the optic nerve at P21, n = 3 animals, 3 nerves for all groups. (<bold>F</bold>) Quantification of myelinated fibers in the optic nerve at P60-P75. <italic>Fig4</italic> control (n = 4 mice, 4 nerves), <italic>Fig4<sup>-/flox</sup>,SynCre</italic> (n = 4 mice, 4 nerves); <italic>Fig4<sup>-/flox</sup>,Olig2Cr</italic>e (n = 3 mice, 4 nerves). Results are shown as mean value ± SEM, one-way ANOVA with multiple comparisons, Tukey posthoc test; n.s. p&gt;0.05, *p=0.0211, **p=0.0055, ****p&lt;0.0001.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.008">http://dx.doi.org/10.7554/eLife.13023.008</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig2-v2"/></fig></p><p>Few axons in the optic nerve of adult <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice showed signs of degeneration (<xref ref-type="fig" rid="fig2">Figure 2C’</xref>). No evidence for axonal degeneration was observed in <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> optic nerves. CNS hypomyelination in <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice was still present at P150, the oldest time point examined by TEM (data not shown). Thus, the optic nerve hypomyelination observed at P21 is not transient in nature but persists into adulthood. We conclude that selective ablation of <italic>Fig4</italic> either in neurons or in the OL lineage leads to profound CNS dysmyelination.</p></sec><sec id="s2-3"><title>Conditional ablation of <italic>Fig4</italic> in neurons or the OL lineage impairs nerve conduction</title><p>To determine whether the morphological defects in CNS myelin of <italic>Fig4</italic> conditional mutants result in functional deficits, we performed electrophysiological recordings. We measured the conduction velocity and amplitude of compound action potentials (CAPs) in optic nerves acutely isolated from P21 mice. Global deletion of <italic>Fig4 (Fig4<sup>-/-</sup></italic>) results in a dramatic reduction in a population of fast conducting fibers and a corresponding increase in the proportion of slowly conducting fibers (<xref ref-type="fig" rid="fig3">Figure 3A,B,E</xref>) (<xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>). The average velocity of the largest peak in <italic>Fig4</italic> control nerves carrying at least one intact allele of <italic>Fig4</italic> is 1.9 ± 0.1 m/s but in <italic>Fig4<sup>-/-</sup></italic> nerves this is reduced to 0.7 ± 0.2 m/s. A similar CAP redistribution was observed in optic nerves prepared from <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice (0.7 ± 0.1 m/s) and <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice (0.6 ± 0.03 m/s) (<xref ref-type="fig" rid="fig3">Figure 3C,D,E</xref>). Thus, consistent with biochemical and morphological analyses (<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig2">2</xref>), loss of <italic>Fig4</italic> in neurons or in the OL-lineage results in slowed nerve conduction.<fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.13023.009</object-id><label>Figure 3.</label><caption><title>Conditional ablation of <italic>Fig4</italic> in neurons or OLs leads to impaired conduction of electrical impulses in the optic nerve.</title><p>Compound action potential (CAP) recordings from acutely isolated optic nerves of P21 mice. (<bold>A</bold>) Representative CAP traces recorded from <italic>Fig4</italic> control mice, harboring at least one <italic>Fig4</italic> WT allele (n = 14 nerves), (<bold>B</bold>) <italic>Fig4<sup>-/-</sup></italic> mice (n = 5 nerves), (<bold>C</bold>) <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice (n = 11 nerves) and (<bold>D</bold>) <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice (n = 9 nerves). For each graph, the arrow indicates the largest amplitude peak, as identified by Gaussian fit. (<bold>E</bold>) Quantification of average conduction velocity of largest amplitude peaks identified in <bold>A-D</bold>. Results are shown as mean value ± SEM, one-way ANOVA with multiple comparisons, Dunnett posthoc, ****p&lt;0.0001.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.009">http://dx.doi.org/10.7554/eLife.13023.009</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13023-fig3-v2"/></fig></p></sec><sec id="s2-4"><title>Reduced number of mature OLs in <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> and <italic>Fig4<sup>-/flox</sup>,SynCre</italic> optic nerves</title><p>To assess the cellular basis of the CNS hypomyelination phenotype, we stained optic nerve cross sections from <italic>Fig4</italic> conditional mutants for markers in the OL lineage. Compared to <italic>Fig4</italic> control optic nerves, the diameter of nerves from P21 <italic>Fig4<sup>-/flox</sup>,SynCre</italic> and <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice were each reduced by 20%. The density of NG2<sup>+</sup> progenitor cells in optic nerve tissue sections is comparable among the three genotypes (<xref ref-type="fig" rid="fig4">Figure 4A–A’’ and D</xref>). The density of Olig2<sup>+</sup> cells, a marker that labels immature and mature OLs, is reduced, as is labeling of <italic>Plp1</italic>, a mature OL marker (<xref ref-type="fig" rid="fig4">Figure 4B-B’’,C–C’’,E and F</xref>). These studies indicate that OPCs are present at normal density and tissue distribution in the <italic>Fig4</italic> conditional null optic nerves, but they fail to generate the normal population of mature myelin-forming OLs.<fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.13023.010</object-id><label>Figure 4.</label><caption><title>Conditional ablation of <italic>Fig4</italic> in neurons or OLs results in a decrease of mature OLs.</title><p>(<bold>A</bold>, <bold>B</bold>, <bold>C</bold>) Optic nerve cross sections from P21 <italic>Fig4</italic> control mice, harboring at least one <italic>Fig4</italic> WT allele, (<bold>A’</bold>, <bold>B’</bold>, <bold>C’</bold>) <italic>Fig4<sup>-/flox</sup>,SynCre</italic> mice and (<bold>A’’</bold>, <bold>B’’</bold>, <bold>C’’</bold>) <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice were stained with anti-NG2, anti-Olig2 or probed for <italic>Plp1</italic> mRNA expression. Scale bar = 100 µm. (<bold>D-F</bold>) Quantification of labeled cells in optic nerve cross sections normalized to area in arbitrary units (A.U.). (<bold>D</bold>) The density of NG2<sup>+</sup> cells in <italic>Fig4</italic> control (n = 4 mice), <italic>Fig4<sup>-/flox</sup>,SynCre</italic> (n = 3 mice) and <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> (n = 3 mice) optic nerves is not significantly (n.s.) different. (<bold>E</bold>) Quantification of the density of Olig2<sup>+</sup> cells in <italic>Fig4</italic> control (n = 6 mice), <italic>Fig4<sup>-/flox</sup>,SynCre</italic> (n = 3 mice) and <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> (n = 4 mice) optic nerves. (<bold>F</bold>) Quantification of the density of <italic>Plp1</italic><sup>+</sup> cells in <italic>Fig4</italic> control (n = 8 mice), <italic>Fig4<sup>-/flox</sup>,SynCre</italic> (n = 4 mice) and <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> (n = 4 mice) optic nerves. Results are shown as mean value ± SEM, one-way ANOVA with multiple comparisons, Dunnett’s posthoc test. **p=0.001, ***p=0.0002 and ****p&lt;0.0001.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.010">http://dx.doi.org/10.7554/eLife.13023.010</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13023-fig4-v2"/></fig></p></sec><sec id="s2-5"><title>Loss of <italic>Fig4</italic> attenuates OL differentiation in vitro</title><p>For a more detailed analysis of the OL lineage, we isolated primary OPCs from P6-P14 <italic>Fig4</italic> pups by anti-PDGFRα immunopanning (<xref ref-type="bibr" rid="bib19">Emery and Dugas, 2013</xref>). Yields of OPCs per brain did not differ between control and <italic>Fig4</italic>-deficient mice (data not shown). OPCs were cultured for two days in vitro (DIV2) under proliferating conditions, fixed and analyzed by double-immunofluorescence staining of Ki67 and PDGFRα. The density of Ki67<sup>+</sup>/PDGFRα<sup>+</sup> cells in <italic>Fig4<sup>+/+</sup></italic> and <italic>Fig4<sup>-/-</sup></italic> cultures is very similar (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–B</xref>). After culture under standard differentiation conditions for 4 days, absence of PDGF and presence of triiodothyronine (T3), OPCs isolated from <italic>Fig4<sup>+/+</sup></italic> (control) or <italic>Fig4<sup>-/-</sup> </italic>pups both acquire a highly arborized morphology and positive staining for OL markers. The density of NG2<sup>+</sup> cells and CNPase<sup>+</sup> cells, normalized to Hoechst 33,342 dye<sup>+</sup> nuclei, is comparable among wildtype and <italic>Fig4-</italic>deficient cultures (<xref ref-type="fig" rid="fig5">Figure 5A–B’, and C</xref>). However, the fraction of cells expressing the more mature OL markers MAG and MBP was significantly reduced in <italic>Fig4<sup>-/-</sup></italic> cultures (<xref ref-type="fig" rid="fig5">Figure 5A–B’, and C</xref>). A more detailed categorization of post-mitotic OLs, based on actin and MBP double-labeling, revealed a significantly decreased number of <italic>Fig4</italic>-deficient OLs that matured to a stage with lamellar MBP<sup>+</sup> membrane sheets (<xref ref-type="bibr" rid="bib80">Zuchero et al., 2015</xref>) (<xref ref-type="fig" rid="fig5">Figure 5D–E</xref>). The reduced number of mature OLs in <italic>Fig4<sup>-/-</sup></italic> cultures was not caused by increased cell death (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C–E</xref>). For a quantitative assessment of protein expression in primary OLs from <italic>Fig4<sup>+/+</sup></italic> and <italic>Fig4<sup>-/-</sup></italic> brains, DIV 3 cultures were lysed and analyzed by capillary Western blotting (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A–C</xref>). FIG4 is clearly detected in <italic>Fig4<sup>+/+</sup></italic> OL lysates but not in <italic>Fig4<sup>-/-</sup> </italic>OL lysates. In <italic>Fig4<sup>-/-</sup></italic> lysates MAG is significantly reduced. Collectively, these data suggest that the initial programs of OL maturation progress normally in the absence of <italic>Fig4</italic> while later stages of OL-differentiation, including lamellar membrane expansion, are <italic>Fig4</italic>-dependent.<fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.13023.011</object-id><label>Figure 5.</label><caption><title><italic>Fig4</italic>-deficient OLs show impaired differentiation and membrane expansion in vitro.</title><p>Representative images of <italic>Fig4</italic> control <italic>(Fig4<sup>+/+</sup> or Fig4<sup>+/-</sup></italic>) and <italic>Fig4<sup>-/-</sup></italic> primary OLs after 4 days in differentiation medium, fixed and stained for the OL-lineage markers (<bold>A </bold>and <bold>A’</bold>) NG2 and MAG; (<bold>B </bold>and <bold>B’</bold>) CNPase and MBP. Scale bar in <bold>A-B’</bold>, 200 µm. (<bold>C</bold>) Quantification of NG2, CNPase, MAG, and MBP/CNPase labeled cells in <italic>Fig4</italic> control (n = 3) and <italic>Fig4<sup>-/-</sup></italic>(n = 3) cultures normalized to Hoechst 33342 dye labeled cells. The ratio of immunolabeled cells over Hoechst<sup>+</sup> cells in <italic>Fig4</italic> control cultures was set at 1. Results are shown as mean value ± SEM, multiple t-test analysis with Holm-Sidak method. **p=0.0075 (MAG), *p=0.012 (MBP). (<bold>D</bold> and <bold>D’</bold>) Confocal images of MBP<sup>+</sup> and Actin Red 555<sup>+</sup> OLs in <italic>Fig4</italic> control and <italic>Fig4<sup>-/-</sup></italic> cultures. Nuclei were labeled with TO-PRO-3, scale bar = 20 µm. (<bold>E</bold>) Quantification of the fraction of “arborized” (actin rich, no MBP), “partial” (partial actin disassembly, onset of MBP expansion), and “ring + lamellar” (full MBP expansion, actin disassembly) in <italic>Fig4</italic> control cultures (n = 4) and <italic>Fig4<sup>-/-</sup></italic> (n = 4) cultures. Results are shown as mean value ± SEM, multiple t-test analysis with Holm-Sidak method. *p=0.0008 (“partial”), *p=0.009 (“ring + lamellar”). The effects of <italic>Fig4</italic> deletion on OPC proliferation and OL survival are shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>. Quantitative Western blot analysis of myelin proteins in primary OL lysates is shown in <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.011">http://dx.doi.org/10.7554/eLife.13023.011</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13023-fig5-v2"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.012</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Loss of <italic>Fig4<sup>-/-</sup></italic> in primary OLs does not affect cell proliferation or cell death.</title><p>(<bold>A-A’</bold>) Representative images of control (<italic>Fig4<sup>+/+</sup></italic> or <italic>Fig4<sup>+/-</sup></italic>) and <italic>Fig4<sup>-/-</sup></italic> OPCs cultured for 2 days under proliferative conditions, fixed and stained with anti-PDGFRα (green) and Ki67 (red). Hoechst 33342 dye was included for nuclear staining of all cells. Scale bar = 200 µm. (<bold>B</bold>) Quantification of PDGFRα and Ki67 double-labeled cells. The number of double stained cells in <italic>Fig4</italic> control cultures was set at 1 and is comparable to <italic>Fig4<sup>-/-</sup></italic> cultures (n = 4 experiments per genotype). Results are shown as mean value ± SEM, unpaired Student’s <italic>t</italic>-test. (<bold>C-C’</bold>) Representative images of OLs after 4 days in T3 containing differentiation medium. Cultures were fixed and stained with calcein-AM (green, living cells) and ethidium homodimer (red, dead cells). Scale bar = 200 µm. Quantification of live cells after 4 days (<bold>D</bold>) and 5 days (<bold>E</bold>) in differentiation medium revealed no differences among the two genotypes. <italic>Fig4</italic>control cultures (n = 4) and <italic>Fig4<sup>-/-</sup></italic> cultures (n = 4). Results are shown as mean value ± SEM, unpaired Students <italic>t</italic>-test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.012">http://dx.doi.org/10.7554/eLife.13023.012</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig5-figsupp1-v2"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.013</object-id><label>Figure 5—figure supplement 2.</label><caption><title>Capillary Western analysis of primary OL lysates.</title><p>(<bold>A</bold>) Representative capillary immunoassay data of <italic>Fig4</italic> control and <italic>Fig4<sup>-/-</sup></italic> OPC/OLs are shown in Simple Western lane view. (<bold>B</bold>) Representative chemiluminescence signal intensity graphs and protein molecular weight of individual proteins. <italic>Fig4</italic> control and <italic>Fig4<sup>-/-</sup></italic> OPC/OLs lysates are shown as black and pink lines respectively. Specific peaks corresponding to each protein target are marked. (<bold>C</bold>) Quantification of protein of Erk1-normalized peak area of each protein target. Three independent experiments were used for quantification. Results are shown as mean value ± SD. *p&lt;0.05; ***p&lt;0.005.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.013">http://dx.doi.org/10.7554/eLife.13023.013</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig5-figsupp2-v2"/></fig></fig-group></p></sec><sec id="s2-6"><title>Independent perturbation of three components of the PI(3,5)P<sub>2</sub> biosynthetic complex all result in severe CNS hypomyelination</title><p>Together with the kinase PIKFYVE and the scaffolding protein VAC14, FIG4 forms a biosynthetic complex necessary for acute interconversion of PI(3) and PI(3,5)P<sub>2</sub>. The complex is located on the cytosolic surface of vesicles trafficking through the LE/Lys compartment (<xref ref-type="bibr" rid="bib44">McCartney et al., 2014</xref>). As an independent test of the effect of perturbation of the FIG4/PIKFYVE/VAC14 enzyme complex on CNS myelination, we generated <italic>Pikfyve<sup>flox/flox</sup>,Olig2cre</italic> mice predicted to be more severely deficient in PI(3,5)P<sub>2</sub> than the FIG4 and VAC14 mutants. Consistent with this expectation, the phenotype of the <italic>Pikfyve</italic> mutant mice is much more severe, with a significant tremor (<xref ref-type="other" rid="media3">Videos 3</xref> and <xref ref-type="other" rid="media4">4</xref>) and death at 2 weeks of age (n = 16 pups). FluoroMyelin Green staining of P13 brain tissue revealed profound hypomyelination of the corpus callosum, internal capsule and cerebellar white matter of <italic>Pikfyve<sup>flox/flox</sup>,Olig2cre</italic> pups (<xref ref-type="fig" rid="fig6">Figure 6A–A’</xref>). In situ hybridization of <italic>Plp1</italic> revealed a virtual absence of mature OLs in the <italic>Pikfyve<sup>flox/flox</sup>,Olig2cre</italic> brain, including structures in the forebrain and cerebellar white matter (<xref ref-type="fig" rid="fig6">Figure 6B–D’</xref>). Toluidine blue staining of P13 optic nerve sections revealed many fibers with clearly visible myelin profiles in <italic>Pikfyve</italic> positive control mice and a striking absence of myelin profiles in <italic>Pikfyve<sup>flox/flox</sup>;Olig2cre</italic> conditional mutants (<xref ref-type="fig" rid="fig6s1">Figure 6—Supplement 1B–D</xref>). Moreover, deficiency of <italic>Pikfyve</italic> in OLs results in a pronounced accumulation of large perinuclear vesicles in the optic nerve (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B,D</xref>). Defects in differentiation of <italic>Pikfyve</italic><sup>-/-</sup> OL cultures are more pronounced than in <italic>Fig4<sup>-/-</sup></italic>OL cultures. Deficiency of <italic>Pikfyve</italic> reduces OPC proliferation (<xref ref-type="fig" rid="fig6">Figure 6E–E' and G</xref>) and results in a 95 ± 1% reduction in cells that progress to the MBP<sup>+</sup> stage, compared with wildtype cells (<xref ref-type="fig" rid="fig6">Figure 6F–F’ and H</xref>). In addition to <italic>Fig4</italic> and <italic>Pikfyve</italic> mutants, we also examined myelinogenesis in the well-characterized recessive <italic>Vac14</italic> mouse mutant L156R (<italic>Vac14<sup>L156R</sup></italic>) (<xref ref-type="bibr" rid="bib34">Jin et al., 2008</xref>). The L156R missense mutation impairs the interaction of VAC14 with PIKFYVE, but not with FIG4 (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Similar to <italic>Fig4<sup>-/-</sup></italic> mice, <italic>Vac14<sup>L156R/L156R</sup></italic> mice exhibit ~50% reduction in PI(3,5)P<sub>2</sub>. Immunoblots of brain membranes prepared from <italic>Vac14<sup>L156R/L156R</sup> </italic>mice showed significantly reduced levels of the myelin markers MAG, CNPase, and MBP (<xref ref-type="fig" rid="fig7">Figure 7B–E</xref>). The electrical properties of optic nerve from <italic>Vac14<sup>L156R</sup></italic> homozygous mice were also impaired, with a significant increase in the population of slowly conducting fibers (<xref ref-type="fig" rid="fig7">Figure 7F–H</xref>). Consistent with this observation, toluidine blue staining of optic nerve sections of adult wild-type mice revealed many myelinated fibers but optic nerves of adult <italic>Vac14<sup>L156R/L156R</sup></italic> mice showed few myelinated fibers (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A–D</xref>). Thus, independent genetic disruptions of the FIG4/PIKFYVE/VAC14 enzyme complex all result in severe hypomyelination and a PI(3,5)P<sub>2</sub> dosage-dependent decline in CNS white matter development.<fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.13023.014</object-id><label>Figure 6.</label><caption><title>Conditional deletion of <italic>Pikfyve</italic> in OLs results in profound CNS hypomyelination.</title><p>(<bold>A-D’</bold>) Sagittal sections of P13 mouse brains. (<bold>A</bold>) <italic>Pikfyve</italic> control (<italic>Pikfyve<sup>flox/+</sup></italic> or <italic>Pikfyve<sup>flox/flox</sup></italic>; n = 3) mice and (<bold>A’</bold>) <italic>Pikfyve</italic> conditional null (<italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre;</italic> n = 3) mice stained with FluoroMyelin Green. In <italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre</italic>, no myelin staining was observed, Scale bar, 1 mm. (<bold>B</bold>-<bold>D’</bold>) in situ hybridization for <italic>Plp1</italic> shows virtual absence of mature OLs in P13 <italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre</italic> brain tissue, including (<bold>B</bold> and <bold>B’</bold>) internal capsule and corpus callosum, (<bold>C’</bold> and <bold>C’</bold>) hippocampus and corpus callosum and (<bold>D</bold> and <bold>D’</bold>) cerebellar white matter. Scale bar (<bold>B-D’</bold>) = 500 µm. (<bold>E-H</bold>) Cultures of primary OPCs/OLs isolated from <italic>Pikfyve</italic> control and <italic>Pikfyve<sup>flox/flox</sup>,Olig2cre</italic> mouse pups. (<bold>E</bold>, <bold>E’</bold>) At DIV2, cells were fixed and stained with anti-PDGFRα, anti-Ki67and Hoechst 33342 dye. (<bold>F</bold>, <bold>F’</bold>) After 3 days in differentiation medium, supplemented with T3, cells were fixed and stained with anti-MBP and Hoechst 33342. (<bold>G</bold>) Quantification of proliferating OPCs revealed a <italic>Pikfyve</italic>-dependent reduction in Ki67<sup>+</sup>/PDGFRα<sup>+</sup> double-labeled cells (n = 3 experiments per genotype). (<bold>H</bold>) Quantification of MBP<sup>+</sup> OLs normalized to Hoechst<sup>+</sup> cells shows a highly significant decrease in the number of MBP<sup>+</sup> OLs in <italic>Pikfyve<sup>flox/flox</sup>,Olig2cre</italic> cultures (n = 3 experiments per genotype). Unpaired Student’s <italic>t</italic>-test; mean value ± SEM. **p=0.011 and ****p&lt;0.0001. Toluidine blue labeling of epoxy resin embedded optics nerves of <italic>Pikfyve</italic> control and <italic>Pikfyve<sup>flox/flox</sup>,Olig2cre</italic> conditional mutant mice is shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.014">http://dx.doi.org/10.7554/eLife.13023.014</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13023-fig6-v2"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.015</object-id><label>Figure 6—figure supplement 1.</label><caption><title>Optic nerve axons are not myelinated in <italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre</italic> mice.</title><p>Semi-thin sections of P14 optic nerves in (<bold>A</bold>, <bold>B</bold>) longitudinal and (<bold>C</bold>, <bold>D</bold>) cross sectional view stained with toluidine blue. In control optic nerve (<italic>Pikfyve<sup>flox/+</sup>,Olig2Cre</italic>) many myelinated fibers are observed (n =3 pups). In <italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre</italic> conditional mutants (n = 3 pups), there is a striking absence of myelinated axons in the optic nerve. Arrows in photomicrographs <bold>B</bold> and <bold>D</bold> point to presumptive oligodendrocytes laden with large vacuoles. Scale bar = 15 μm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.015">http://dx.doi.org/10.7554/eLife.13023.015</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig6-figsupp1-v2"/></fig></fig-group><fig-group><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.13023.016</object-id><label>Figure 7.</label><caption><title>Homozygosity for <italic>VAC14<sup>L156R</sup></italic> leads to CNS hypomyelination and impaired conduction of compound action potentials.</title><p>(<bold>A</bold>) Schematic of the PIKfyve/Vac14/Fig4 enzyme complex and its phosphoinositide products PI(3)P and PI(3,5)P<sub>2</sub>. The red asterisk in VAC14 indicates the L156R point mutation that perturbs the interaction with PIKfyve, but not with Fig4. (<bold>B</bold>) Western blot analysis of brain membranes prepared from adult (P90-120) WT and <italic>VAC14<sup>L156R</sup>/VAC14<sup>L156R</sup></italic> littermate mice revealed a reduction in the myelin markers MAG, CNPase, and MBP. Anti-class III β-tubulin (βIII-Tub), a neuronal marker, is shown as a loading control. (<bold>C-E</bold>) Quantification of protein bands detected by Western blotting, shows a significant decrease in MAG, CNPase, and MBP in <italic>VAC14</italic> mutant brain tissue (n = 3 independent blots per genotype). Unpaired Student’s <italic>t</italic>-test; mean value ± SEM. ***p&lt;0.001, **p=0.0015 and *p=0.0238. (<bold>F</bold> and <bold>G</bold>) Representative CAP traces recorded from acutely isolated optic nerves of WT and <italic>VAC14<sup>L156T</sup></italic> homozygous mice. (<bold>H</bold>) Quantification of average conduction velocity (CV) of largest amplitude peaks identified in <bold>F</bold> and <bold>G</bold>. Results are shown as mean value ± SEM, unpaired Student’s <italic>t</italic>-test, **p=0.0063. WT n = 6 nerves, 3 mice and for <italic>Vac14<sup>L156R</sup></italic> mutants n = 6 nerves, 3 mice. Toluidine blue staining of epoxy resin embedded optic nerve sections from <italic>VAC14<sup>L156R</sup>/VAC14<sup>L156R</sup></italic> mice is shown in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.016">http://dx.doi.org/10.7554/eLife.13023.016</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13023-fig7-v2"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.017</object-id><label>Figure 7—figure supplement 1.</label><caption><title>Severe optic nerve hypomyelination in <italic>VAC14<sup>L156R/L156R</sup></italic> mice.</title><p>Semi-thin sections of P21 optic nerves in (<bold>A</bold>, <bold>B</bold>) longitudinal and (<bold>C</bold>, <bold>D</bold>) cross sectional view stained with toluidine blue. In wildtype (WT) optic nerve sections many myelinated fibers are observed (n = 3 pups). In marked contrast, very few axons are myelinated in the <italic>VAC14<sup>L156R/L156R</sup></italic> optic nerves (n = 2). Scale bar = 15 μm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.017">http://dx.doi.org/10.7554/eLife.13023.017</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig7-figsupp1-v2"/></fig></fig-group><media content-type="glencoe play-in-place height-250 width-310" id="media3" mime-subtype="mp4" mimetype="video" xlink:href="elife-13023-media3.mp4"><object-id pub-id-type="doi">10.7554/eLife.13023.018</object-id><label>Video 3.</label><caption><title>Normal locomotion of juvenile <italic>Pikfyve<sup>flox/+</sup></italic> control mice.</title><p>A representative video of a control <italic>Pikfyve<sup>flox/+</sup> </italic>mouse at P13. N = 16</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.018">http://dx.doi.org/10.7554/eLife.13023.018</ext-link></p></caption></media><media content-type="glencoe play-in-place height-250 width-310" id="media4" mime-subtype="mp4" mimetype="video" xlink:href="elife-13023-media4.mp4"><object-id pub-id-type="doi">10.7554/eLife.13023.019</object-id><label>Video 4.</label><caption><title>Severe tremor in juvenile <italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre</italic> mice.</title><p>A representative video of a <italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre</italic> conditional mutant mouse at P13 reveals a severe tremor phenotype. N = 16</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.019">http://dx.doi.org/10.7554/eLife.13023.019</ext-link></p></caption></media></p></sec><sec id="s2-7"><title>Myelin proteins are present within enlarged LAMP1<sup>+</sup> perinuclear vacuoles in primary OLs from <italic>Fig4<sup>-/-</sup></italic> mice</title><p>The FIG4/PIKFYVE/VAC14 biosynthetic complex regulates intracellular PI(3,5)P<sub>2</sub> and thereby influences membrane trafficking through the endo-lysosomal system. DIV2 primary OPC cultures established from <italic>Fig4</italic> control (<italic>Fig4<sup>+/+</sup></italic> or <italic>Fig4<sup>-/+</sup></italic>) and <italic>Fig4<sup>-/-</sup></italic> mice were fixed and subjected to anti-LAMP1 and anti-PDGFRα double-immunofluorescence labeling. The majority of <italic>Fig4<sup>-/-</sup></italic> OPCs showed normal-sized lysosomes with a diameter of &lt; 1 µm, while a fewcells (&lt; 20% ) exhibited enlarged LAMP1<sup>+</sup> vesicles (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1A–B”</xref>). Upon OL differentiation, an increase in size and number of perinuclear LAMP1<sup>+</sup> vesicles is observed in <italic>Fig4<sup>-/-</sup></italic>cultures. The enlarged perinuclear LAMP1<sup>+</sup> structures are prominently labeled with anti-MAG (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1C–D”</xref>). In a parallel approach, <italic>Fig4<sup>-/-</sup></italic> OLs were transfected with <italic>Rab7-YFP</italic>, a reporter for LE. Enlarged perinuclear vacuoles in Fi<italic>g4<sup>-/-</sup></italic> OLs are positive for Rab7-YFP (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2A–A’</xref>). Live imaging of primary OLs revealed that the majority of enlarged perinuclear vacuoles in <italic>Fig4<sup>-/- </sup></italic>OLs are stable for several days. However, vacuole size varies and live imaging revealed that some vacuoles appear and disappear over a period of 12 hr (<xref ref-type="other" rid="media5">Video 5</xref>). Collectively, these studies demonstrate that in <italic>Fig4<sup>-/-</sup></italic> OLs, myelin building blocks that are normally trafficked through the LE/Lys are present in abnormal, enlarged vesicles the majority of which is stable for several days.<media content-type="glencoe play-in-place height-250 width-310" id="media5" mime-subtype="mp4" mimetype="video" xlink:href="elife-13023-media5.mp4"><object-id pub-id-type="doi">10.7554/eLife.13023.020</object-id><label>Video 5.</label><caption><title>Vacuoles in <italic>Fig4<sup>-/-</sup></italic> OLs appear and disappear within hours.</title><p>Time-lapse live cell analysis of <italic>Fig4<sup>-/-</sup></italic> primary OPC/OLs imaged with an IncuCyte ZOOM microscope. Phase contrast images were taken every 2 hr over a time interval of 60 hr. The majority of <italic>Fig4<sup>-/-</sup></italic> cells contain large perinuclear vacuoles. Some of these vacuoles appear and disappear within hours (n = 3). Scale bar = 60 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.020">http://dx.doi.org/10.7554/eLife.13023.020</ext-link></p></caption></media></p></sec><sec id="s2-8"><title>Cell surface derived MAG is trapped in large vacuoles in the LE/Lys compartment in <italic>Fig4<sup>-/-</sup></italic> OLs</title><p>In developing OLs, myelin proteins such as MAG and PLP transiently accumulate on the plasma membrane (PM) at the cell soma, prior to undergoing endocytosis and LE/Lys dependent transport to the myelin sheet (<xref ref-type="bibr" rid="bib71">Winterstein et al., 2008</xref>). To monitor trafficking of MAG, we used antibody tagging in live OL cultures. In wildtype OLs, anti-MAG-Alexa488 binds to MAG on the PM surface, undergoes endocytosis and is targeted to LAMP1<sup>+</sup> vesicles in the LE/Lys compartment (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2B–B”</xref>). In these wildtype cultures, anti-MAG<sup>+</sup> vesicles are small, with a median volume of 0.3 ± 0.06 µm<sup>3</sup>, and partially overlap with LysoTracker<sup>+</sup> vesicles (<xref ref-type="fig" rid="fig8">Figure 8A–A”</xref>). In contrast, in <italic>Fig4<sup>-/-</sup></italic> OLs, anti-MAG-Alexa488 is endocytosed and accumulates in LAMP1<sup>+</sup> perinuclear vacuoles with greatly enlarged size (≥5 µm<sup>3</sup>, mean volume 94 ± 41 µm<sup>3</sup>) and also in smaller MAG<sup>+</sup>/LAMP1<sup>+</sup> vesicles with a median volume of 0.7 ± 0.25 µm<sup>3</sup>. The average size of all vesicles in <italic>Fig4<sup>-/- </sup></italic>OLs is 1.65 ± 0.32 µm<sup>3</sup> (<xref ref-type="fig" rid="fig8">Figure 8B–B” and C</xref>, <xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2C–C”</xref>). This suggests that independent of <italic>Fig4</italic> genotype, MAG is transported to the PM and is rapidly endocytosed. In <italic>Fig4<sup>-/-</sup></italic> OLs, large MAG<sup>+</sup>/LAMP1<sup>+</sup> vesicles rarely overlap with LysoTracker staining (<xref ref-type="fig" rid="fig8">Figure 8B-8B”</xref>), suggesting that large vesicles may exhibit reduced acidification. As an independent approach to assess whether perturbation of PI(3,5)P<sub>2</sub> synthesis causes accumulation of MAG in large perinuclear vacuoles, wildtype OL cultures were treated with 1 µM apilimod, a potent inhibitor of PIKfyve (<xref ref-type="bibr" rid="bib8">Cai et al., 2013</xref>). Treatment with apilimod for 90–120 min leads to the formation of large perinuclear vacuoles laden with MAG (<xref ref-type="fig" rid="fig8">Figure 8D–D”</xref>), similar to those in <italic>Fig4<sup>-/-</sup></italic> OLs. To evaluate the specificity of the anti-MAG-Alexa488 antibody, experiments were repeated with primary OLs isolated from <italic>Mag<sup>-/-</sup></italic> pups (<xref ref-type="bibr" rid="bib50">Pan et al., 2005</xref>). Bath application of anti-MAG-Alexa488 to <italic>Mag<sup>-/-</sup></italic> OLs treated with vehicle or apilimod did not result in immunostaining, demonstrating that the antibody is specific for MAG (<xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3A–D”</xref>). The myelin protein MOG has a different endocytotic fate from MAG, trafficking through recycling endosomes (RE) but not the lysosomal compartment (<xref ref-type="bibr" rid="bib71">Winterstein et al., 2008</xref>). Simultaneous antibody labeling of cell surface MAG and MOG in live OLs confirmed distinct endocytotic trafficking routes in both <italic>Fig4</italic> control and <italic>Fig4<sup>-/-</sup> </italic>cultures. Importantly, in <italic>Fig4<sup>-/-</sup></italic> OLs, MOG was not present in the enlarged vacuoles that are typically laden with MAG (<xref ref-type="fig" rid="fig8s4">Figure 8—figure supplement 4A–B”</xref>). This suggests that the defect in <italic>Fig4<sup>-/-</sup></italic> OLs in trafficking of myelin building blocks from the PM is specific for trafficking through the LE/Lys compartment and does not affect trafficking through the RE.<fig-group><fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.13023.021</object-id><label>Figure 8.</label><caption><title>In <italic>Fig4<sup>-/-</sup></italic> OLs, MAG accumulates in large perinuclear vacuoles.</title><p>Confocal images of live OLs acutely labeled with bath applied anti-MAG-Alexa488 (green) and LysoTracker Deep Red. (<bold>A-A’’</bold>) <italic>Fig4</italic> control (<italic>Fig4<sup>+/+</sup></italic> or <italic>Fig4<sup>+/-</sup>)</italic> OLs incubated with anti-MAG-Alexa488 and LysoTracker, single channel and merged images are shown. (<bold>B-B”</bold>) <italic>Fig4<sup>-/- </sup></italic>OLs incubated with anti-MAG-Alexa488 and Lysotracker shows accumulation of MAG in large perinuclear vacuoles (arrows), single channel and merged images are shown. Of note, large perinucler MAG<sup>+</sup> vacuoles do not stain with LysoTracker. (<bold>C</bold>) Scatter plot depicting the volume of anti-MAG-Alexa488<sup>+</sup> particles in live <italic>Fig4</italic> control and <italic>Fig4<sup>-/- </sup></italic>OLs. Each dot represents an individual vesicle (n = 4 experiments, 9 cells per genotype). Mean volumes ± SEM are shown. (<bold>D-D”</bold>) Wildtype OLs were incubated with anti-MAG-Alexa488 and LysoTracker and then acutely treated with the PIKfyve inhibitor apilimod. MAG accumulates in large perinuclear vacuoles, the majority of which does not stain with LysoTracker (n = 4 for <italic>Fig4</italic> controls and n = 4 for <italic>Fig4<sup>-/-</sup></italic>cultures). For apilimod treatment, n = 3 independent cultures. Maximum projection confocal z-stack images are shown, scale bar = 10 μm. Further characterization of enlarged perinuclear vacuoles in <italic>Fig4<sup>-/-</sup></italic> OL cultures, specificity control for the anti-MAG-Alexa488 antibody and distinct trafficking routes of MAG and MOG are shown in <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>–<xref ref-type="fig" rid="fig8s3">3</xref> and <xref ref-type="fig" rid="fig8s4">4</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.021">http://dx.doi.org/10.7554/eLife.13023.021</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13023-fig8-v2"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.022</object-id><label>Figure 8—figure supplement 1.</label><caption><title><italic>Fig4<sup>-/-</sup> </italic>OLs show enlarged perinuclear vacuoles that stain positive for LAMP1.</title><p>Confocal images of (<bold>A-A”</bold>) <italic>Fig4</italic> control (<italic>Fig4<sup>+/+</sup></italic> or <italic>Fig4<sup>+/-</sup></italic>) and (<bold>B-B”</bold>) <italic>Fig4<sup>-/-</sup></italic>OPCs cultured for two days in the presence of PDGF, fixed and double-stained with anti-LAMP1 and anti-PDGFRα antibodies. TO-PRO-3 dye was added to stain nuclei. Few OPCs (&lt;20%) in <italic>Fig4<sup>-/-</sup></italic> cultures showed enlarged LAMP1<sup>+</sup> vesicles (white arrows). (<bold>C-D’’</bold>) Confocal images of (<bold>C-C”</bold>) <italic>Fig4</italic> control and (<bold>D-D”</bold>) <italic>Fig4<sup>-/- </sup></italic>OLs after 4 days in T3 containing differentiation medium. Cultures were fixed and double-stained with anti-LAMP1 and anti-MAG antibodies. TO-PRO-3 dye was added to stain nuclei. In <italic>Fig4<sup>-/-</sup></italic> cultures, the majority of OLs (&gt;65%) showed multiple large perinuclear vacuoles that were double-positive for LAMP1and MAG (white arrows). Observations were made in 4 independent experiments per culture condition. Scale bar, <bold>A-D”</bold> = 10 μm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.022">http://dx.doi.org/10.7554/eLife.13023.022</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig8-figsupp1-v2"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.023</object-id><label>Figure 8—figure supplement 2.</label><caption><title>In <italic>Fig4<sup>-/- </sup></italic>OLs, PM derived MAG is transported to enlarged vesicles in the LE/Lys compartment.</title><p>Representative confocal images of (<bold>A</bold>) <italic>Fig4</italic> control OLs and (<bold>A’</bold>) <italic>Fig4<sup>-/- </sup></italic>OLs transfected with a <italic>Rab7-YFP</italic> expression construct. Large perinuclear Rab7-YFP<sup>+</sup> vesicular structures are observed in <italic>Fig4<sup>-/-</sup></italic> OLs (arrows). Scale bar = 20 μm. Confocal images of (<bold>B-B”</bold>) <italic>Fig4</italic> control (<italic>Fig4<sup>+/+</sup></italic> or <italic>Fig4<sup>+/-</sup></italic>) and (<bold>C-C”</bold>) <italic>Fig4<sup>-/- </sup></italic>OL cultures transfected with a <italic>LAMP1-mCherry</italic> expression construct and incubated in bath applied anti-MAG-Alexa488 antibody. (<bold>B”</bold>) In <italic>Fig4</italic> control cultures MAG is localized to LAMP1<sup>+</sup> vesicles with a diameter of less than 1 µm. (<bold>C”</bold>) In <italic>Fig4<sup>-/-</sup></italic>cultures, MAG labeling is frequently observed in enlarged perinuclear and LAMP1<sup>+</sup> vesicles (arrows). Scale bar = 20 μm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.023">http://dx.doi.org/10.7554/eLife.13023.023</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig8-figsupp2-v2"/></fig><fig id="fig8s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.024</object-id><label>Figure 8—figure supplement 3.</label><caption><title>Specificity control for anti-MAG-Alexa488 antibody.</title><p>Live-cell imaging of primary OLs prepared from <italic>Mag<sup>+/+</sup></italic> and <italic>Mag<sup>-/-</sup></italic>pups following bath application of anti-MAG-Alexa488 (green) and LysoTracker Deep Red. Representative confocal Z-stack images are shown. (<bold>A-A”</bold>) Anti-MAG-488 labeling of intracellular vesicles is robust in <italic>Mag<sup>+/+</sup></italic> OLs. (<bold>B-B”</bold>) No signal is detected in parallel processed <italic>Mag</italic><sup>-/-</sup> OLs. Independent of <italic>MAG</italic> genotype, prominent LysoTracker staining is observed. (<bold>C-D’’</bold>) To rule out the possibility that large vacuoles are non-specifically labeled by anti-MAG-Alexa488, <italic>Mag<sup>+/+</sup></italic> and <italic>Mag<sup>-/-</sup></italic>OL cultures were treated with the PIKfyve kinase inhibitor apilimod. Apilimod leads to accumulation of enlarged perinuclear vacuoles in <italic>Mag<sup>+/+</sup></italic>and <italic>Mag<sup>-/-</sup></italic>cultures. (<bold>C-C’’</bold>) In <italic>Mag<sup>+/+</sup></italic> cultures, vacuoles are strongly labeled with anti-MAG-Alexa488. (<bold>D-D’’</bold>) In <italic>Mag<sup>-/-</sup></italic> cultures, no labeling with anti-MAG-Alexa488 was observed. Scale bar in <bold>A-D”</bold> = 7.5 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.024">http://dx.doi.org/10.7554/eLife.13023.024</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig8-figsupp3-v2"/></fig><fig id="fig8s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.025</object-id><label>Figure 8—figure supplement 4.</label><caption><title>Live imaging of primary OLs reveals distinct trafficking routes for PM-derived MAG and MOG.</title><p>Confocal images of (<bold>A-A”</bold>) <italic>Fig4</italic> control and (<bold>B-B”</bold>) <italic>Fig4<sup>-/-</sup></italic> OLs simultaneously incubated with anti-MAG-Alexa488 and anti-MOG-Alexa555 antibodies. Independent of <italic>Fig4</italic> genotype, there is little overlap among MAG<sup>+</sup> (green) and MOG<sup>+</sup> (red) structures. In <italic>Fig4<sup>-/-</sup></italic> OLs, enlarged MAG<sup>+</sup> vesicular structures (arrows) are MOG<sup>-</sup>. Scale bar <bold>A-B’</bold> = 7.5 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.025">http://dx.doi.org/10.7554/eLife.13023.025</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig8-figsupp4-v2"/></fig></fig-group></p></sec><sec id="s2-9"><title><italic>Fig4<sup>-/-</sup></italic> OLs display impaired MAG trafficking through the LE/Lys compartment</title><p>The perinuclear location and large size of MAG<sup>+</sup> vacuoles suggests that their mobility may be compromised, potentially leading to impaired trafficking of MAG and other myelin building blocks transported via the LE/Lys route. To explore this possibility, we assessed movement of MAG<sup>+</sup> vesicles in live OLs using time-lapse imaging (<xref ref-type="fig" rid="fig9">Figure 9A–B’</xref>). Small vesicles labeled with anti-MAG-Alexa488 are observed in <italic>Fig4<sup>+/+</sup></italic> and <italic>Fig4<sup>-/-</sup></italic> primary OLs, with average volumes of 0.3 µm<sup>3</sup> and 0.7 µm<sup>3</sup>, respectively. The average velocity of these 'normal-sized' vesicles is comparable in <italic>Fig4<sup>+/+</sup></italic> and <italic>Fig4<sup>-/-</sup></italic> cells: 0.09 ± 0.01 µm/s and 0.07 ± 0.01 µm/s, respectively (<xref ref-type="fig" rid="fig9">Figure 9C</xref>). The large MAG<sup>+</sup> vesicles in the <italic>Fig4<sup>-/- </sup></italic>OLs with an average volume of 94 ± 41 µm<sup>3</sup> are more stationery, with an average velocity of 0.033 ± 0.005 µm/s (<xref ref-type="fig" rid="fig9">Figure 9C</xref>), and they fail to reach the nascent myelin sheet. These data suggest that trafficking of MAG and other LE/Lys dependent myelin building blocks is impaired in the <italic>Fig4<sup>-/-</sup></italic> OLs. Collectively, these studies indicate that PI(3,5)P<sub>2</sub> is critical for myelin protein trafficking through the LE/Lys compartment in developing OLs.<fig id="fig9" position="float"><object-id pub-id-type="doi">10.7554/eLife.13023.026</object-id><label>Figure 9.</label><caption><title>In <italic>Fig4<sup>-/-</sup></italic> OLs, vesicular trafficking through the LE/Lys compartment is defective.</title><p>Representative confocal images of live, anti-MAG-Alex488 labeled (<bold>A</bold>) <italic>Fig4</italic> control OLs and (<bold>A’</bold>) <italic>Fig4<sup>-/-</sup></italic> OLs. Time-lapse imaging was used to track movement of MAG<sup>+</sup> vesicles. (<bold>B</bold>) Using Imaris software, MAG<sup>+</sup> vesicles were labeled with pink spheres and vesicular movement was tracked (yellow lines) in <italic>Fig4</italic> control cultures. (<bold>B’</bold>) Imaris software was used to track movement of large vesicles (white color) and small vesicles (purple color) in <italic>Fig4<sup>-/- </sup></italic>OLs: tracks of individual vesicles are shown. (<bold>C</bold>) Quantification of mean velocity of MAG<sup>+</sup> vesicles in <italic>Fig4</italic> control OLs and <italic>Fig4<sup>-/- </sup></italic>OLs. In <italic>Fig4<sup>-/-</sup></italic> OLs, movement of small vesicles (0.7 µm<sup>3</sup>) and large vesicles (94 µm<sup>3</sup>) was assessed separately. The velocity is shown as mean value ± SEM. N = 4 independent experiments and a total of 9 cells per genotype were analyzed. One-way ANOVA with Dunnett posthoc, ***p= 0.001. (n.s. = not significant).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.026">http://dx.doi.org/10.7554/eLife.13023.026</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13023-fig9-v2"/></fig></p></sec><sec id="s2-10"><title>PI(3,5)P<sub>2</sub> is important for myelin membrane trafficking in live brain slices</title><p>Inter-cellular communication is critical for proper development of the axo-glial unit. To extend the studies of myelin protein trafficking to a system that contains intact axo-glial units, we prepared acute forebrain slices from P10-P14 mice and kept them in oxygenated artificial cerebrospinal fluid. Trafficking of MAG was monitored by bath application of mouse anti-MAG-Alexa555 for 2 hr at 32°C. To distinguish between endocytosed MAG and PM localized MAG, brain slices were fixed and incubated with a secondary anti-mouse-Alexa488 conjugated antibody under non-permeabilizing conditions. Endocytosed MAG containing vesicles were prominently found in OL perinuclear regions and along cellular processes that form the myelin internode (<xref ref-type="fig" rid="fig10">Figure 10A–A”</xref>). Only a small fraction of MAG is labeled with both antibodies, and thus localized to the PM on the cell surface (<xref ref-type="fig" rid="fig10">Figure 10A–A”</xref>). To visualize cells in the OL lineage, we repeated MAG trafficking studies with brain slices from the <italic>ROSA-LacZ/EGFP,Olig2Cre</italic> reporter mouse. Vesicular MAG labeling was abundant in EGFP<sup>+</sup> cells, indicating that endocytosis of PM localized MAG does occur in cells of the OL-lineage and vesicular labeling is not the result of nonspecific antibody uptake by microglia or other cell types (<xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1A–C</xref>). To control for antibody specificity, brain slices from <italic>Mag<sup>-/-</sup></italic> mice were processed in parallel and revealed no significant labeling (<xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1D–F</xref>). Thus, acute brain slices provide an opportunity to study myelin protein trafficking in live tissue. To assess whether PI(3,5)P<sub>2</sub> is required for endocytosis and trafficking of PM derived MAG in live brain tissue, the experiment was repeated with forebrain slices prepared from <italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre</italic> pups. Strikingly, in the absence of PI(3,5)P<sub>2</sub>, MAG<sup>+</sup> labeling was restricted to abnormal perinuclear accumulations, and trafficking to cell processes was virtually absent (<xref ref-type="fig" rid="fig10">Figure 10B’–B”</xref>). The data demonstrate that in brain slices, as well as cultured cells, PI(3,5)P<sub>2</sub> is required for proper membrane trafficking from the PM through the LE/Lys compartment.<fig-group><fig id="fig10" position="float"><object-id pub-id-type="doi">10.7554/eLife.13023.027</object-id><label>Figure 10.</label><caption><title>Impaired trafficking of MAG in <italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre</italic> brain slices.</title><p>Confocal images of acute brain slices in oxygenated ACSF treated with bath-applied anti-MAG-Alexa555 antibody, fixed and stained with anti-mouse-Alexa488 secondary antibody to distinguish between endocytosed MAG (red) and PM localized MAG (green). (<bold>A</bold>) OLs in the striatum of <italic>Pikfyve</italic> control mice (P13) show punctate MAG labeling in the cell soma (arrows) and along processes that form internodes. Only few MAG<sup>+</sup> structures are also stained with anti-mouse-Alexa488, and thus, localized on the PM. (<bold>B-B”</bold>) Limited perinuclear MAG labeling is observed in the <italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre</italic> striatum. Many MAG<sup>+</sup> structures are labeled red and green, and thus localized to the PM, however intracellular MAG is observed in some cells. Scale bar = 20 µm. Small inset shows a 3D view of the two cells labeled with arrows (<bold>B-B”</bold>). MAG<sup>+</sup> vesicles (red) only partially overlap with PM localized MAG (green). Alexa488<sup>+</sup> isosurface transparency is adjusted to 50% to demonstrate intracellular Alexa555<sup>+</sup> (red) and LiveNuc 647<sup>+</sup> (blue) structures. Scale bar = 10 µm. To directly demonstrate that anti-MAG antibody labeled cells are OLs, parallel experiments were carried out with brain slices of <italic>LacZ/EGFP,Olig2Cre</italic> reporter mice. Anti-MAG antibody specificity is demonstrated with <italic>Mag<sup>-/-</sup></italic>slices in <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.027">http://dx.doi.org/10.7554/eLife.13023.027</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13023-fig10-v2"/></fig><fig id="fig10s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13023.028</object-id><label>Figure 10—figure supplement 1.</label><caption><title>Anti-MAG labeling of EGFP<sup>+</sup> OLs and specificity control for anti-MAG antibody in acute brain slices.</title><p>(<bold>A-C</bold>) The <italic>LacZ/EGFP,Olig2Cre</italic> reporter mouse was used for genetic labeling of cells in the OL lineage. In acute brain slices, punctate anti-MAG-Alexa555 labeling is observed in the soma and processes of EGFP<sup>+</sup> OLs in the developing neocortex of P14 mice (arrow). For nuclear staining slices were incubated with NucRed 647. Insert: Isosurface rendering of the MAG<sup>+</sup>/EGFP<sup>+</sup> cell labeled with the arrow. EGFP<sup>+</sup> isosurface transparency is increased to 50% to demonstrate intracellular Alexa555<sup>+</sup> (red) and LiveNuc 647<sup>+</sup> (blue) structures. Scale bar = 10 µm. (<bold>D-F</bold>) Parallel processed brain slices from <italic>Mag<sup>-/-</sup></italic>pups labeled live with mouse anti-MAG-Alexa555 antibody, fixed and incubated with anti-mouse Alexa488, show no staining above background. Scale bar = 20 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13023.028">http://dx.doi.org/10.7554/eLife.13023.028</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13023-fig10-figsupp1-v2"/></fig></fig-group></p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Multiple independent means of perturbing the Fig4/Vac14/PIKfyve enzyme complex all lead to profound CNS hypomyelination. Remarkably, conditional ablation of <italic>Fig4</italic> either in neurons or OLs is sufficient to disrupt normal CNS myelination, indicating that both OL-intrinsic and OL-extrinsic mechanisms of OL maturation function in a <italic>Fig4</italic>-dependent manner. The hypomyelination phenotype in <italic>Fig4</italic> conditional mutants and <italic>VAC14<sup>L156R</sup></italic> mice is physiologically relevant since it is associated with substantially reduced amplitude and conduction velocity of compound action potentials. Primary OPCs deficient in <italic>Fig4</italic> progress normally to the stage of NFOs but their differentiation into mature OLs is impaired. In <italic>Fig4<sup>-/-</sup></italic> OLs, MAG is trafficked to the PM, undergoes endocytosis and is localized to enlarged LAMP1<sup>+</sup> perinuclear vacuoles. The reduced motility of the enlarged MAG/LAMP1<sup>+</sup> vacuoles and their perinuclear position suggests that myelin building blocks are trapped in the LE/Lys compartment and cannot be delivered to the developing myelin sheath. Conditional deletion of <italic>Pikfyve</italic> in the OL lineage leads to more pronounced defects characterized by impaired OL differentiation, greatly reduced myelin membrane trafficking and profound CNS dysmyelination. Together, these studies firmly establish a critical role for the FIG4/PIKFYVE/VAC14 enzyme complex, and by extension its lipid product PI(3,5)P<sub>2</sub>, in myelin protein trafficking through the LE/Lys system in developing OLs and proper assembly of the axo-glial unit.</p><sec id="s3-1"><title>Impaired PI(3,5)P<sub>2</sub> metabolism attenuates OL differentiation</title><p>Immunohistological studies of <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> optic nerves and experiments with <italic>Fig4<sup>-/-</sup></italic> primary OLs did not detect a significant change in OPC density or reduction in viability. OPCs deficient for <italic>Fig4</italic> progress and differentiate normally to the stage of newly formed OLs (NFOs), a postmitotic cell type characterized as PDGFRα<sup>-</sup>, GalC<sup>+</sup>, MOG<sup>-</sup> (<xref ref-type="bibr" rid="bib77">Zhang et al., 2014</xref>). However, differentiation of NFOs into mature OLs is PI(3,5)P<sub>2</sub>-dosage dependent. The arrest of OL differentiation becomes more severe as PI(3,5)P<sub>2</sub> levels are reduced to ~50% of wildtype levels, in <italic>Fig4</italic> and <italic>VAC14</italic> mice, or completely depleted in <italic>Pikfyve</italic> mutant mice. OL maturation is highly regulated, and can be attenuated or blocked by perturbation of numerous signaling pathways and transcriptional programs (<xref ref-type="bibr" rid="bib18">Emery et al., 2009</xref>; <xref ref-type="bibr" rid="bib5">Bercury and Macklin, 2015</xref>; <xref ref-type="bibr" rid="bib41">Marinelli et al., 2016</xref>). The fate of immature OLs that fail to progress to the mature stage remains unclear. However, these cells are likely to be short-lived and destined to die. The number of activated caspase-3<sup>+</sup> cells in the OL lineage of <italic>Fig4<sup>-/-</sup></italic> mice is not significantly increased (<xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>), suggesting that immature OLs either do not die in large numbers or die in a caspase-independent manner. Additional studies are needed to determine exactly at which stage of OL lineage progression PI(3,5)P<sub>2</sub> deficiency impairs differentiation and how PI(3,5)P<sub>2</sub> regulates progression to a mature myelin producing cell.</p></sec><sec id="s3-2"><title><italic>Fig4</italic>-dependent trafficking of myelin building blocks through the LE/Lys</title><p>Like epithelial cells, OLs are polarized, with the myelin sheath resembling the apical membrane domain and the membrane near the OL cell body the basolateral membrane domain (<xref ref-type="bibr" rid="bib56">Salzer, 2003</xref>; <xref ref-type="bibr" rid="bib39">Maier et al., 2008</xref>; <xref ref-type="bibr" rid="bib42">Masaki, 2012</xref>). Myelin-producing OLs synthesize and transport large quantities of myelin building blocks (lipids and proteins) in order to segmentally ensheath multiple axons. Myelinogenesis also requires membrane sorting and trafficking to specific subdomains of the nascent myelin membrane sheath. Indeed, the final destination of myelin proteins may vary between compact myelin (e.g. PLP), peri-axonal loops (MAG) or abaxonal loops (MOG) of non-compact myelin (<xref ref-type="bibr" rid="bib1">Arroyo and Scherer, 2000</xref>, <xref ref-type="bibr" rid="bib56">Salzer, 2003</xref>; <xref ref-type="bibr" rid="bib69">White and Kramer-Albers, 2014</xref>). As in other polarized cells, OL proteins may be targeted through direct transport pathways from the Golgi to their final destination (<xref ref-type="bibr" rid="bib56">Salzer, 2003</xref>). Alternative strategies are also employed to target key myelin constituents to their final destination. The mRNA for MBP, encoding a protein important for axon wrapping and myelin compaction, is packaged into RNA-granules and transported to distal sites within OL processes for regulated translation (<xref ref-type="bibr" rid="bib46">Müller et al., 2013</xref>). MAG, PLP, and MOG are synthesized in the endoplasmatic reticulum and transported through the Golgi network to the PM near the OL cell body (analogous to the basolateral domain) as an intermediate target. From there MOG is targeted to the recycling endosome (RE) while MAG and PLP are targeted to the LE/Lys for delivery to the myelin sheath (analogous to the apical membrane domain) (<xref ref-type="bibr" rid="bib61">Simons and Trajkovic, 2006</xref>; <xref ref-type="bibr" rid="bib39">Maier et al., 2008</xref>; <xref ref-type="bibr" rid="bib71">Winterstein et al., 2008</xref>). LAMP1 is a marker for LE/Lys and we show that MAG is targeted to LAMP1<sup>+</sup> vesicles in both <italic>Fig4<sup>+/+</sup></italic> and <italic>Fig4<sup>-/- </sup></italic>OLs. A key feature of the MAG/LAMP1 double-labeled vesicles in <italic>Fig4<sup>-/-</sup></italic> mutant OLs is their greatly enlarged size and perinuclear position. The average velocity of these vesicles is significantly reduced, suggesting impaired membrane trafficking through the LE/Lys compartment. Trafficking defects in <italic>Fig4<sup>-/-</sup></italic> OLs are confined to the LE/Lys compartment as trafficking of MOG through RE occurs apparently normal, independent of <italic>Fig4</italic> genotype. The severe CNS hypomyelination phenotype in <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> mice is likely not the result of impaired MAG trafficking alone, but rather the result of mistrafficking of numerous myelin building blocks normally migrating through the LE/Lys compartment. For example, cholesterol (in part bound to PLP) and glycosphingolipids are endocytosed from the PM and stored in LE/Lys vesicles (<xref ref-type="bibr" rid="bib65">Trajkovic et al., 2006</xref>, <xref ref-type="bibr" rid="bib71">Winterstein et al., 2008</xref>). During OL maturation, neuronal signals trigger a profound redistribution of PLP-containing membrane domains; endocytosis is reduced and PLP together with cholesterol and glycosphingolipids is moved from the LE/Lys to the PM (<xref ref-type="bibr" rid="bib65">Trajkovic et al., 2006</xref>). In humans, impaired trafficking of PLP due to mutation or altered dosage of the <italic>Plp1</italic> gene, causes Pelizaeus-Merzbacher disease (PMD) and Spastic Paraplegia Type 2 (SPG2), developmental disorders with severe neurological impairment (<xref ref-type="bibr" rid="bib30">Inoue, 2005</xref>). Overexpression of PLP in mice leads to accumulation of the protein in autophagic vesicles and LE/Lys, leading to reduction of other myelin proteins such MBP, MAG, and MOG (<xref ref-type="bibr" rid="bib36">Karim et al., 2007</xref>). As in <italic>Fig4<sup>-/-</sup></italic> mice, PMD results in reduced number of OLs and CNS dysmyelination. Failure of lysosomal trafficking or function is thus a common underlying mechanism for a growing number of hereditary disorders that cause CNS dysmyelination, including PMD, Niemann-Pick type C disease, and several lysosomal storage diseases (<xref ref-type="bibr" rid="bib24">Folkerth, 1999</xref>; <xref ref-type="bibr" rid="bib72">Yaghootfam et al., 2005</xref>; <xref ref-type="bibr" rid="bib52">Prolo et al., 2009</xref>; <xref ref-type="bibr" rid="bib59">Schweitzer et al., 2009</xref>; <xref ref-type="bibr" rid="bib20">Faust et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Grishchuk et al., 2014</xref>).</p></sec><sec id="s3-3"><title>PI(3,5)P<sub>2</sub>-dependent trafficking of myelin membrane components in developing OLs</title><p>Different phosphoinositides exhibit unique distribution to intracellular membrane compartments and have been implicated as key regulators of membrane sorting and targeted vesicular trafficking (<xref ref-type="bibr" rid="bib43">Mayinger, 2012</xref>). PI(3,5)P<sub>2</sub>, for example, decorates vesicles in the LE/Lys compartment and serves as a docking site for cytosolic proteins (<xref ref-type="bibr" rid="bib43">Mayinger, 2012</xref>). PIP binding proteins frequently interact with small GTPases belonging to the Rab or Arf families, establishing a combinatorial code that defines membrane identity (<xref ref-type="bibr" rid="bib4">Behnia and Munro, 2005</xref>; <xref ref-type="bibr" rid="bib63">Stenmark, 2009</xref>; <xref ref-type="bibr" rid="bib32">Jean and Kiger, 2012</xref>; <xref ref-type="bibr" rid="bib43">Mayinger, 2012</xref>; <xref ref-type="bibr" rid="bib17">Egami et al., 2014</xref>). The phosphorylation status of PIPs and the activation state of small GTPases can be rapidly modified, providing an identification code that is both unique and dynamic, two prerequisites for targeted membrane transport. In HeLa cells, for example, the lysosomal membrane is characterized by the presence of PI(3,5)P<sub>2</sub> and the small GTPases Rab7 and Arf-like (<xref ref-type="bibr" rid="bib7">Bucci et al., 2000</xref>; <xref ref-type="bibr" rid="bib27">Hofmann and Munro, 2006</xref>). In fibroblasts cultured from <italic>Fig4<sup>-/-</sup></italic> or <italic>VAC14<sup>L156R/L156R</sup></italic> mice, PI(3,5)P<sub>2</sub> levels are reduced by ~50% leading to formation of greatly enlarged LAMP1<sup>+</sup> vacuoles (<xref ref-type="bibr" rid="bib12">Chow et al., 2007</xref>; <xref ref-type="bibr" rid="bib34">Jin et al., 2008</xref>; <xref ref-type="bibr" rid="bib78">Zou et al., 2015</xref>). In <italic>Fig4<sup>-/- </sup></italic>OLs, Rab7-YFP localizes to large perinuclear vacuoles (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>). In HeLa cells, overexpression of constitutively active Rab7 leads to formation of large LAMP1<sup>+</sup> and LAMP2<sup>+</sup> vacuoles (<xref ref-type="bibr" rid="bib7">Bucci et al., 2000</xref>). A direct interaction of VAC14 with the Rab7 GTPase activating protein (GAP) TBC1D15 has recently been described in HeLa cells (<xref ref-type="bibr" rid="bib58">Schulze et al., 2014</xref>). This suggests the existence of a large protein complex that controls the interconversion of PI(3)P and PI(3,5)P<sub>2</sub> and the activity of select Rab GTPases, an emerging theme for directed membrane trafficking (<xref ref-type="bibr" rid="bib33">Jean et al., 2015</xref>). Rab GTPases constitute a large protein family whose members are localized to distinct intracellular membrane microdomains to coordinate vesicle trafficking (<xref ref-type="bibr" rid="bib63">Stenmark, 2009</xref>; <xref ref-type="bibr" rid="bib28">Hutagalung and Novick, 2011</xref>). The GTPase Rab3A is expressed in OLs and has been shown to participate in membrane trafficking and myelination (<xref ref-type="bibr" rid="bib57">Schardt et al., 2009</xref>). As discussed above, transport of myelin membrane components, including PLP, cholesterol and MAG, involves membrane sorting and trafficking through the LE/Lys compartment prior to insertion into the nascent myelin sheath (<xref ref-type="bibr" rid="bib69">White and Kramer-Albers, 2014</xref>). Thus, interference with PI(3,5)P<sub>2</sub> synthesis, turnover, or binding partners that define LE/Lys membrane identity results in impaired cargo delivery of key myelin membrane components required for membrane expansion and sheath formation.</p></sec><sec id="s3-4"><title>Neuronal <italic>Fig4</italic> participates in CNS myelination</title><p>The severe hypomyelination phenotype in <italic>Fig4<sup>-/flox</sup>, SynCre</italic> mice suggests that <italic>Fig4</italic>-dependent neuronal signals are necessary for proper CNS myelination. When coupled with our previous finding that transgenic <italic>Fig4</italic> directed by the NSE promoter on a <italic>Fig4<sup>-/-</sup></italic>background (<italic>Fig4<sup>-/-</sup>,NSE-Fig4</italic>) rescues the myelination defect (<xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Ferguson et al., 2012</xref>), this suggests that normal levels of <italic>Fig4</italic> in neurons is necessary for CNS myelination and that neuronal overexpression of recombinant <italic>Fig4</italic> on a global <italic>Fig4<sup>-/-</sup></italic> background is sufficient to drive CNS myelination. Multiple lines of evidence have demonstrated that neuron-derived signals regulate OL maturation and axon myelination (<xref ref-type="bibr" rid="bib13">Coman et al., 2005</xref>; <xref ref-type="bibr" rid="bib65">Trajkovic et al., 2006</xref>; <xref ref-type="bibr" rid="bib49">Ohno et al., 2009</xref>; <xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>; <xref ref-type="bibr" rid="bib75">Yu and Lieberman, 2013</xref>; <xref ref-type="bibr" rid="bib73">Yao et al., 2014</xref>). We speculate that neuronal <italic>Fig4</italic> regulates LE/Lys-dependent transport and axonal presentation of a 'pro-myelination' signal(s) necessary for OL differentiation and CNS axon myelination and that transgenic overexpression of <italic>Fig4</italic> in neurons (NSE-Fig4) leads to an elevated production of 'pro-myelination' signals(s) sufficient to rescue the deficiency of <italic>Fig4</italic> in the OL lineage of the <italic>Fig4<sup>-/-</sup>,NSE-Fig4</italic> transgenic mice. Alternatively, neuronal <italic>Fig4</italic> may accelerate the loss of 'anti-myelination' signal(s) on the axonal surface, e.g., through endocytosis. Inter-cellular communication may occur through paracrine action of secreted molecules or shedding vesicles. Exosomes are extracellular vesicles produced by many cells that facilitate transport and exchange of proteins, mRNAs and regulatory RNAs with important functions in cellular processes including myelination (<xref ref-type="bibr" rid="bib25">Frühbeis et al., 2012</xref>; <xref ref-type="bibr" rid="bib53">Pusic and Kraig, 2014</xref>). Because <italic>Fig4</italic> plays an important role in membrane trafficking through the LE/Lys system, it is possible that protein secretion or the content and abundance of exosomes may be altered in the mutant mice. Two independent approaches to delete <italic>Fig4</italic> in the OL lineage (<italic>Olig2Cre</italic> and <italic>PdgfrαCreER</italic>) revealed that <italic>Fig4</italic> is required in the OL lineage for proper CNS myelination. These data were corroborated by in vitro studies with primary OLs. Taken together, our observations suggest that endogenous levels of <italic>Fig4</italic> gene expression in both neurons and OLs are necessary for normal CNS myelination.</p><p>Technical limitations in the specificity of transgene promoters may affect the interpretation of these experiments. For neuron-specific loss-of-function we employed female <italic>SynapsinCre/+</italic> mice driven by a synapsin-1 gene (SYN1) promoter fragment (<xref ref-type="bibr" rid="bib55">Rempe et al., 2006</xref>), and for neuron-specific gain-of-function studies we used a 4.6 kb <italic>NSE</italic> promoter fragment (<xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Ferguson et al., 2012</xref>). While these are commonly used strategies, it is recognized that in the developing mouse the <italic>NSE</italic> (ENO2) and <italic>SYN1</italic> promoters may have some leakiness that results in transient expression in non-neuronal cells including glia. A low level of expression of the endogenous <italic>SYN1</italic> and <italic>ENO2</italic> genes in OPCs/OLs has been reported (<xref ref-type="bibr" rid="bib77">Zhang et al., 2014</xref>), but it is not clear whether this expression is retained by the promoter fragments that were used to drive transgene expression. Independent of these technical limitations, we provide multiple lines of evidence that genetic manipulations that compromise PI(3,5)P<sub>2</sub> synthesis profoundly impact OL differentiation and CNS myelination.</p></sec><sec id="s3-5"><title>Novel assay to monitor myelin protein trafficking in brain tissue</title><p>Acutely prepared brain slices are viable for several hours when maintained in oxygenated ACSF, a method commonly used for electrophysiological recordings (<xref ref-type="bibr" rid="bib37">Lee et al., 2008</xref>). Studies with primary OLs suggest that newly synthesized myelin proteins are initially transported to the PM near the cell soma where they interact with lipids and other myelin proteins (<xref ref-type="bibr" rid="bib71">Winterstein et al., 2008</xref>). These myelin-like structures are then thought to be endocytosed and trafficked to specific subdomains of the nascent myelin membrane sheath. Using acute brain slices combined with genetic labeling of cell in the OL lineage and confocal microscopy, we show that antibody-labeled MAG on the PM becomes rapidly endocytosed and is found in small vesicles in the OL cell soma and long processes that form internodes. Since sorting and trafficking of myelin building blocks are key components of myelinogenesis, future studies using acute brain slices may be productively combined with pharmacological and genetic manipulations to obtain detailed understanding of membrane trafficking in developing OLs.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Transgenic mice</title><p>All mice were housed and cared for in accordance with NIH guidelines, and all research conducted was done with the approval of the University of Michigan Committee on Use and Care of Animals. The spontaneous <italic>Fig4<sup>-/-</sup></italic> null mutation plt (<xref ref-type="bibr" rid="bib12">Chow et al., 2007</xref>) is maintained as two congenic lines, C57BL/6J.plt/+ and C3HeB/FeJ.plt/+. F1 plt/plt homozygotes obtained from crosses between these lines survive to 30–45 days, permitting analysis of myelination, and these were used for most experiments. A subset of in vitro experiments was carried out on cells from the C3HeB/FeJ.plt congenic mice. The conditional <italic>Fig4<sup>flox</sup></italic> allele was described elsewhere <xref ref-type="bibr" rid="bib22">(Ferguson et al., 2012</xref>) and is maintained on strain C3HeB/FeJ from which the retinal degeneration locus <italic>rd</italic> was removed by repeated backcrossing and selection. Neuron-specific conditional knockout mice (<italic>Fig4<sup>-/flox</sup>,SynCre</italic>) were generated and maintained as previously described <xref ref-type="bibr" rid="bib22">(Ferguson et al., 2012</xref>). The <italic>Olig2Cre/+</italic> line (<xref ref-type="bibr" rid="bib60">Schüller et al., 2008</xref>) and the <italic>PdgfraCre-ER/</italic>+ (<xref ref-type="bibr" rid="bib35">Kang et al., 2010</xref>) (Jackson Laboratory stock # 018280) were used to delete <italic>Fig4</italic> in the OL lineage. For inducible gene ablation in <italic>Fig4<sup>-/flox</sup>,PdfrαCreER</italic> mice, 4-hydroxytamoxifen (4OH-tamoxifen) (Sigma-Aldrich, MO) was injected directly into the stomach of P5 pups, which is easily identified by its milky-white color. 4OH-tamoxifen was dissolved in 100% ethanol at 10 mg/ml and 5 μl/day were administered for 2 days. <italic>Fig4<sup>-/flox</sup>,Hb9Cre (Fig4<sup>-/flox</sup>,Mnx1Cre)</italic> mice have been described previously (<xref ref-type="bibr" rid="bib66">Vaccari et al., 2015</xref>). The spontaneous point mutant <italic>VAC14<sup>L156R</sup></italic> is deficient in PIKfyve binding (<xref ref-type="bibr" rid="bib34">Jin et al., 2008</xref>) and was maintained on a C3HeB/FeJ strain background from which the retinal degeneration locus <italic>rd</italic> was removed by repeated backcrossing. <italic>Pikfyve<sup>flox/flox</sup></italic> mice were generated on the C57BL/6J strain background (<xref ref-type="bibr" rid="bib81">Min et al., 2014</xref>) and were crossed with <italic>Olig2Cre/+</italic> mice. <italic>Mag<sup>-/-</sup> </italic>mice on a C57BL/6J background have been described elsewhere (<xref ref-type="bibr" rid="bib50">Pan et al., 2005</xref>). LacZ/ EGFP reporter mice (Jackson laboratory stock #003920) were crossed with <italic>Olig2Cre/+</italic> mice.</p></sec><sec id="s4-2"><title>Transmission electron microscopy (TEM)</title><p>Postnatal day (P)21 and P60-P75 mice were deeply anesthetized with ketamine (200 mg/kg)/xylazine (20 mg/kg body weight) and perfused transcardially with ice-cold phosphate buffer saline (PBS) for 2 min, followed by 4% paraformaldehyde (PFA) and 2.5% glutaraldehyde in Sorensen’s buffer and embedded in epoxy resin as described (<xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>). Semi-thin sections were stained with toluidine blue for light microscopy. TEM micrographs were taken at 10,500–13,500x magnification with a Philips CM-100 or a JEOL 100CX microscope and analyzed using FIJI software. <italic>Fig4<sup>-/flox</sup>,Hb9Cre</italic> (<xref ref-type="bibr" rid="bib66">Vaccari et al., 2015</xref>), <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> and <italic>Fig4<sup>-/flox</sup>,SynCre</italic> conditional mutants were analyzed and compared to littermate controls. Throughout the study, control mice are defined as mice that have at least one intact copy of the <italic>Fig4</italic> allele and include the following genotypes (i) <italic>Fig4<sup>+/-</sup></italic>, (ii) <italic>Fig4<sup>-/flox</sup></italic>, (iii) <italic>Fig4<sup>+/flox</sup>,Olig2Cre</italic> and (iv) <italic>Fig4<sup>+/flox</sup>,SynCre</italic>.</p></sec><sec id="s4-3"><title>Immunohistochemistry</title><p>Mice between P10 and adulthood were perfused transcardially with ice-cold 4% PFA in PBS. Brains were post-fixed in perfusion solution for 2 hr at 4°C for in situ hybridization. For immunofluorescence labeling, brains were postfixed overnight and cryoprotected in 30% sucrose in PBS. For FluoroMyelin staining, brains were cryosectioned at 25–40 μm. Free-floating sections were rinsed 3x 5 min in PBS and then stained with FluoroMyelin Green (Millipore, MA, 1:200) in PBS for 20 min. Sections were washed with PBS, mounted onto microscope slides, coverslipped with Prolong Gold antifade supplemented with DAPI (Life Technologies, CA) and imaged with an Olympus IX71 microscope attached to a DP72 camera. For immunofluorescence labeling of optic nerves, nerves were rapidly dissected, kept in perfusion solution for 30 min and cryoprotected in 30% sucrose in PBS. Cross sections (12–20 µm) were mounted onto microscope slides, rinsed 3x for 5 min in PBS and incubated for 1 hr in blocking solution: 1% horse serum and 0.1% Triton-X100 in PBS (anti-Olig2) or 4% normal goat serum and 0.3% Triton-X100 in PBS (anti-NG2). Primary antibody incubation was done overnight at 4°C in blocking solution with rabbit anti-Olig2 (1:1000 Millipore) or rabbit anti-NG2 (1:800, Abcam, UK). The next day, sections were rinsed 3x 5 min with PBS, incubated with appropriate secondary antibodies for 1 hr at room temperature (1:1000, Alexa-conjugated, Life technologies), rinsed in PBS and mounted in Prolong Gold supplemented with DAPI.</p></sec><sec id="s4-4"><title>RNA in situ hybridization</title><p>cDNA fragments of <italic>Mbp and Plp1</italic> (<xref ref-type="bibr" rid="bib74">Ye et al., 2009</xref>) were used to produce digoxigenin-labeled cRNA probe by run-off in vitro transcription. Brains were cryosectioned at 25 μm and mounted directly onto Superfrost<sup>+</sup> microscope slides (Fisher Scientific, MA). Optic nerve sections were prepared as described above and postfixed in 4% PFA/PBS overnight at 4°C. The following day, sections were rinsed with 1x PBS and dehydrated with series of ethanol dilutions (50%, 70%, 95%, and 100%). Sections were then treated with 50µg/ml proteinase K in PBS/5mM EDTA for 15 min (optic nerves) and 30 min for brain sections. All subsequent steps were performed as described previously (<xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>).</p></sec><sec id="s4-5"><title>Isolation of brain membranes</title><p>P21 mouse brains were homogenized in a Wheaton Dounce tissue homogenizer cooled on ice. Brain membranes were isolated by centrifugation in a discontinuous sucrose gradient as described previously (<xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>).</p></sec><sec id="s4-6"><title>Isolation of brain tissue</title><p>P21 control littermate and <italic>Fig4<sup>-/flox</sup>,PdfrαCreER </italic>brains were extracted and rapidly dissected on ice. Tissue was separated into two groups: 1) cerebellum + brainstem and 2) neocortex + hippocampus + thalamus ('forebrain'). Tissue was lysed in a radio-immunoprecipitation assay buffer (RIPA) using a tissue homogenizer and triturated with a 16G needle. Lysates were spun at 14,000 rpm for 15 min at 4°C and supernatants were analyzed by Western blotting as described below.</p></sec><sec id="s4-7"><title>Western blot analysis</title><p>Equal amounts of protein (7.5–15 µg) from brain membranes were separated by SDS-PAGE and transferred onto PVDF membranes (Millipore). Membranes were blocked in 3% dry milk powder dissolved in Tris-HCl pH 7.4 buffered saline containing 0.3% Triton X-100 for at least 1 hr and incubated with primary antibody overnight at 4°C. Primary antibodies included mouse anti-βIII tubulin (1:20,000; Promega, WI), rabbit anti-MAG (1:1000; <xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>), rat anti-MBP (1:1000; Millipore), mouse anti-CNPase (1:1000, Abcam), anti-PLP (1:1000, Abcam), and mouse anti-Fig4 (1:200, NeuroMab, CA). Primary antibodies were detected using either horseradish peroxidase (HRP)-conjugated secondary antibodies (1:2000–15000; Millipore Bioscience Research Reagents) or Alexa-conjugated secondary antibodies (1:20,000, Molecular Probes). The Licor C-DiGit and Odyssey imaging systems and software were used for visualization and quantification of protein bands (Licor, NE).</p></sec><sec id="s4-8"><title>Electrophysiology</title><p>Recordings were carried out as described elsewhere (<xref ref-type="bibr" rid="bib10">Carbajal et al., 2015</xref>). Briefly, juvenile (P21-P23) and adult (3–4 months) mice were sacrificed by CO<sub>2</sub> inhalation. Optic nerves were rapidly dissected, incubated at room temperature in oxygenated artificial cerebrospinal fluid (ACSF) for 45 min and then transferred to a temperature-controlled recording chamber (held at 37 ± 0.4°C) with oxygenated ACSF. Each end of the nerve was drawn into the tip of a suction pipette electrode. The stimulating electrode was connected to a constant-current stimulus isolation unit (WPI, FL) driven by Axon pClamp 10.3 software and a 50 μs pulse was applied to the retinal end of the nerve. The recording electrode was applied to the chiasmatic end of the nerve and connected to the input of a differential AC amplifier (custom-made). A second pipette, placed near the recording pipette but not in contact with the nerve, served to subtract most of the stimulus artifact from the recordings. Signals were digitized at 100 kHz through a data acquisition system (Axon Digidata 1440A, Axon pClamp 10.3, Molecular Devices, CA).</p></sec><sec id="s4-9"><title>Primary OL cultures and immunocytochemistry</title><p>OPCs were isolated from P6-14 mouse pups with the following genotypes (i) <italic>Fig4<sup>+/+</sup></italic>, (ii) <italic>Fig4<sup>+/-</sup></italic>, (iii) <italic>Fig4<sup>-/-</sup></italic>, (iv) <italic>Fig4<sup>-/flox</sup>,Olig2Cre</italic> or (v) <italic>Pikfyve<sup>flox/flox</sup>,Olig2Cre</italic>. For immunopanning, anti-PDGFRα (BD Biosciences, CA) or O4 antibody (hybridoma cells kindly provided by Dr Jonah Chan) coated plates were used, as described <xref ref-type="bibr" rid="bib19">(Emery and Dugas, 2013</xref> ). For the first two days in vitro, OPCs were cultured on poly-D-lysine (Sigma-Aldrich) coated glass coverslips in DMEM-SATO medium supplemented with forskolin (Sigma, 10 ng/ml), PDGF (20 ng/ml, Peprotech, NJ), CNTF (10 ng/ml, Peprotech), and NT3 (1 ng/ml, Peprotech). For differentiation studies, OPCs were switched to medium supplemented with T3 (40 ng/ml, Sigma-Aldrich) without growth factors. Cells were allowed to differentiate for 4–6 days prior to fixation in 4% PFA/PBS at RT for 15 min. For immunofluorescence labeling, cells were rinsed 3x 5 min each in PBS, permeabilized with 0.1% Triton-X100 in PBS for 30 min and blocked for 60 min in 3% BSA in PBS. The following primary antibodies were used: rabbit anti-NG2 (1:500, Millipore), rat anti-PDGFRα (1:1000, BD Biosciences, CA), rabbit anti-PDGFRα (1:500, Cell Signaling, MA), rat anti-MBP (1:300, Millipore), rabbit anti-CNPase (1:1000, Assay Biotech, CA), rabbit anti-Ki67 (1:1000, Abcam), mouse anti-MAG (1:300, Millipore), rat anti-Lamp1 (1:1000, Abcam), mouse anti-GFAP (1:2000, Sigma-Aldrich). Cells were incubated with primary antibodies overnight at 4°C. The following day, cells were rinsed 3x 5 min each with PBS, and incubated with secondary antibodies for 1 hr in blocking solution. Following several rinses in PBS, cells were incubated with the nuclear markers Hoechst 33,342 or ToPro3 dye (Life Technologies) and imaged with an Olympus IX71 inverted microscope (Olympus, JP) with a DP72 camera or a Leica SP5 confocal microscope (Leica, DE). Representative confocal images were taken at 63x magnification as z-stacks with 1 µm intervals. Maximum intensity z projections were generated using Fiji. For cell viability experiments, the Live/Dead kit (Life Technologies) was used following the manufacturer’s instructions. For actin staining, Actin Red 555 (Life Technologies) was used following the manufacturer’s instructions.</p><p>For live cell imaging, OPCs were switched to T3 supplemented differentiation medium and kept at 37°C in a 5% CO<sub>2</sub> incubator equipped with an IncuCyte Zoom imaging system (Essen Bioscience, MI). Images were taken with a 20x objective every 2 hr for 3 days. Data were analyzed using the IncuCyte Zoom software and Fiji.</p></sec><sec id="s4-10"><title>Live cell imaging</title><p>O4<sup>+</sup> primary OLs were isolated by immunopanning as described above and cultured in 35 mm glass bottom dishes (Mattek, MA). After 2–3 days under differentiation conditions, anti-MAG-Alexa488 conjugated antibody (1:500, Millipore, MAB1567A4) was added to the culture medium for 12–14 hr. The following day, LysoTracker Deep Red (1:2000, Life Technologies) was added to the culture medium for 30–45 min. Fifteen minutes before imaging, the culture medium was replaced by 1x HBSS (Life Technologies) containing Prolong Live Antifade reagent (Life Technologies, 1:100) and Hoechst dye 33,342 (1:50,000) or NucRed Live 647 (Life Technologies). Cells were imaged at 37°C and ambient CO<sub>2</sub> for 15–20 min/dish using a Leica SP5 confocal microscope. Confocal Z-stacks, xyt, and xyzt videos were acquired. As a specificity control for the anti-MAG-Alexa488 antibody, OLs were prepared from <italic>Mag<sup>-/-</sup></italic> and age-matched <italic>Mag<sup>+/+</sup></italic> pups and imaged under identical conditions. Mouse monoclonal anti-MOG antibody (Millipore) was conjugated with Alex555 using the Antibody Labeling Kit (Life Technologies). Some OL cultures were incubated with anti-MOG-Alexa555 (1:250) and anti-MAG-Alexa488 as described above. To some cultures 1 μM apilimod (Axon 1369; Axon Medchem BV) in DMSO was added 90–120 min prior to imaging. Images and videos were processed using Leica AS LF and Fiji. Tracking and movement analysis of anti-MAG-Alexa488<sup>+</sup> particles in live cells was performed using Imaris (Bitplane, UK).</p></sec><sec id="s4-11"><title>Ex vivo MAG labeling</title><p>To monitor MAG trafficking in acute brain tissue, sagittal slices were prepared from P13-P14 pups with the following genotypes, (i) <italic>Pikfyve</italic> control mice, (ii) littermates <italic>Pikfyve <sup>flox/flox</sup>,Olig2Cre</italic> mice, (iii) <italic>Mag<sup>-/-</sup>,</italic> mice and (iv) P18 <italic>LacZ/EGFP, Olig2Cre </italic>reporter mice (<xref ref-type="bibr" rid="bib64">Toth et al., 2013</xref>). Briefly, mice were decapitated, brains rapidly dissected and submerged in ice-cold ACSF (<xref ref-type="bibr" rid="bib64">Toth et al., 2013</xref>). From forebrain tissue, hippocampi were removed and discarded. Cortex and striatum were sectioned at 300 µm using a tissue slicer (WPI, FL). Brain slices were kept in oxygenated (95% O<sub>2,</sub> 5% CO<sub>2</sub>) ACSF at RT for 40–60 min prior to incubation with anti-MAG-Alexa-555 (1:500) in oxygenated ACSF at 32°C for 2 hr. Brain slices were then fixed in 4% PFA for 25 min, rinsed 3 times for 10 min each in PBS and incubated overnight with a goat anti-mouse Alexa-488 secondary antibody (1:1000) in 3% BSA at 4°C. The following day, slices were rinsed 3 times for 10 min each in PBS, incubated with LiveRed 647 for 25 min at RT, rinsed 3 times for 10 min each in PBS, and mounted in Prolong antifade with DAPI. Individual MAG<sup>+</sup> cells in deep cortical layers and striatum were imaged using a Leica SP5 confocal microscope.</p></sec><sec id="s4-12"><title>Primary OL transfection</title><p>For transfection of primary OPC/OLs, Lipofectamine2000 (Life Technologies) was used, following a protocol previously established for transfection of primary neurons (<xref ref-type="bibr" rid="bib16">Duan et al., 2014</xref>). Briefly, 250 ng of <italic>LAMP1-mCherry</italic> or <italic>Rab7-YFP</italic> plasmid DNA were combined with 1 µl of Lipofectamine2000 (Invitrogen, CA) in optiMEM and mixed thoroughly. Transfection solution was added to OL culture medium and cells were incubated for 2.5 hr. Afterwards, the medium was completely replaced with fresh T3 supplemented medium. To visualize MAG trafficking, anti-MAG-Alexa-488 antibody was added to the culture medium as described above. The following day, live imaging of LAMP1-mCherry<sup>+</sup>/anti-MAG-Alexa-488<sup>+</sup> OLs was carried out as described above.</p></sec><sec id="s4-13"><title>Western blot analysis of OPC cultures</title><p>OPCs were allowed to expand in PDGF supplemented culture medium for 7–8 days, passaged and plated in 6-well culture dishes at a density of 200,000–300,000 cells/well and kept for 3 days in T3 supplemented medium. Cells were then processed for Western blotting as previously described (<xref ref-type="bibr" rid="bib54">Raiker et al., 2010</xref>). Capillary immunoassays were performed using the automated Wes system (ProteinSimple, San Jose CA). All procedures were performed according to manufacturer’s protocol. In brief, 0.8 µg of lysate (4 µl) were mixed with 2 µl of 5x fluorescent master mix and boiled for 5 min. These samples were dispensed into microplates along with blocking solution, primary and secondary antibodies and chemiluminescent substrate. After centrifugation, microplate was loaded into the Wes instrument for subsequent protein separation on capillaries and immuno-detection using the standard electrophores, immunolabeling, detection scheme of Wes. Data were analyzed by using Compass software (ProteinSimple) and peak areas were used for quantification. Erk1 peak area was used for normalization between samples. Three independent preparations were processed.</p></sec><sec id="s4-14"><title>Statistical analysis</title><p>To assess myelination in the optic nerve, ten non-overlapping TEM images were randomly selected and the fraction of myelinated axons quantified as described (<xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>). At least 600 axons were quantified per nerve. G-ratio analysis was performed as described previously (<xref ref-type="bibr" rid="bib70">Winters et al., 2011</xref>). At least 100 axons per optic nerve were analyzed. For Western blot analysis, Western band intensity was measured using LI-COR Studio Image Software. All band intensities were normalized either to βIII-tubulin (brain lysates and membranes) or actin (OPC cultures). Normalized Western blot band intensity for control samples was set as 1 for each experiment. For optic nerve electrophysiology, data analysis was performed offline using Clampfit software. In order to analyze individual peaks, each trace was fitted as a sum of three or four Gaussians using Origin Pro software (<xref ref-type="bibr" rid="bib11">Chen et al., 2004</xref>). A peak with the largest amplitude in each trace was used for conduction velocity analysis.</p><p>For quantification of <italic>Plp1</italic>, Olig2, and NG2 labeled cells, the number of respective positive cells was quantified per optic nerve cross section and normalized to the section area (arbitrary units in FIJI). At least four sections per nerve were analyzed.</p><p>For quantification of OL markers in vitro, ten non-overlapping images were taken at random positions for each coverslip/well and cells positive for a marker of interest counted and normalized to the number of Hoechst 33,342 dye positive cells in the same image. A minimum of 900 cells was quantified for each individual experiment with <italic>Fig4 </italic>cultures and a minimum of 120 cells was quantified for each individual experiment with <italic>Pikfyve</italic> cultures. GFAP<sup>+</sup> astrocytes were excluded from quantification. The analysis of actin/MBP postmitotic OL morphology was performed as characterized previously (<xref ref-type="bibr" rid="bib80">Zuchero et al., 2015</xref>).</p><p>For cell viability experiments, the Live/Dead kit was used the number of live (green) and dead (red) cells was quantified and the live/total cell ratio was calculated. For all experiments, Hoechst 33,342 normalized cell density in control groups was set as 1. At least three independent experiments with duplicate coverslips were used for the analysis. For live imaging of MAG<sup>+</sup> vesicles in primary OLs, Imaris software (Bitplane) was used to calculate individual particle speed and size. Four independent experiments were analyzed for <italic>Fig4<sup>+/+</sup></italic>and <italic>Fig4<sup>-/-</sup></italic> cultures. MAG<sup>+</sup> particles of at least 0.01 µm<sup>3</sup> in volume were included in data analysis.</p><p>One-way ANOVA followed by Tukey posthoc was used for TEM optic nerve analysis. One-way ANOVA followed by Dunnett’s posthoc was used for Western blot analysis and electrophysiology with more than two groups. The unpaired Student t-test was used for analysis in all experiments with two groups.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank members of Giger lab for their feedback on manuscript preparation, Ben Barres and Ronald Schnaar for providing <italic>Olig2Cre</italic> and <italic>Mag<sup>-/-</sup></italic>mice, respectively, Bradley Zuchero for his advice on OPC immunopanning, Jonah Chan for providing O4 hybridoma cells, Bill Tsai and Takamasa Inoue for the Rab7-YFP plasmid, Richard Lu for the Plp1 plasmid, and Lois Weisman for apilimod We thank Margaret Youngman for assistance with optic nerve electrophysiology and Brian Pierchala and Jennifer Shadrach for help with confocal microscopy.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>YAM, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con2"><p>GML, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con3"><p>J-PL, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con4"><p>SJL, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con5"><p>JLT, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con6"><p>IV, Acquisition of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con7"><p>AB, Drafting or revising the article, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con8"><p>LAH, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con9"><p>SHM, Acquisition of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con10"><p>CSA, Drafting or revising the article, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con11"><p>PS, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con12"><p>MHM, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con13"><p>RJG, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to protocols approved by the University committee on use and care for animals (UCUCA protocols: #00005863 and #00005902) of the University of Michigan.</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arroyo</surname><given-names>EJ</given-names></name><name><surname>Scherer</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>On the molecular architecture of myelinated fibers</article-title><source>Histochemistry and Cell Biology</source><volume>113</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1007/s004180050001</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barres</surname><given-names>BA</given-names></name><name><surname>Raff</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons</article-title><source>Nature</source><volume>361</volume><fpage>258</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1038/361258a0</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baulac</surname><given-names>S</given-names></name><name><surname>Lenk</surname><given-names>GM</given-names></name><name><surname>Dufresnois</surname><given-names>B</given-names></name><name><surname>Ouled Amar Bencheikh</surname><given-names>B</given-names></name><name><surname>Couarch</surname><given-names>P</given-names></name><name><surname>Renard</surname><given-names>J</given-names></name><name><surname>Larson</surname><given-names>PA</given-names></name><name><surname>Ferguson</surname><given-names>CJ</given-names></name><name><surname>Noé</surname><given-names>E</given-names></name><name><surname>Poirier</surname><given-names>K</given-names></name><name><surname>Hubans</surname><given-names>C</given-names></name><name><surname>Ferreira</surname><given-names>S</given-names></name><name><surname>Guerrini</surname><given-names>R</given-names></name><name><surname>Ouazzani</surname><given-names>R</given-names></name><name><surname>El Hachimi</surname><given-names>KH</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name><name><surname>Leguern</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria</article-title><source>Neurology</source><volume>82</volume><fpage>1068</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000000241</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behnia</surname><given-names>R</given-names></name><name><surname>Munro</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Organelle identity and the signposts for membrane traffic</article-title><source>Nature</source><volume>438</volume><fpage>597</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1038/nature04397</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bercury</surname><given-names>KK</given-names></name><name><surname>Macklin</surname><given-names>WB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dynamics and mechanisms of CNS myelination</article-title><source>Developmental Cell</source><volume>32</volume><fpage>447</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.01.016</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bharadwaj</surname><given-names>R</given-names></name><name><surname>Cunningham</surname><given-names>KM</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Lloyd</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>FIG4 regulates lysosome membrane homeostasis independent of phosphatase function</article-title><source>Human Molecular Genetics</source><volume>25</volume><fpage>681</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv505</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucci</surname><given-names>C</given-names></name><name><surname>Thomsen</surname><given-names>P</given-names></name><name><surname>Nicoziani</surname><given-names>P</given-names></name><name><surname>McCarthy</surname><given-names>J</given-names></name><name><surname>van Deurs</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Rab7: a key to lysosome biogenesis</article-title><source>Molecular Biology of the Cell</source><volume>11</volume><fpage>467</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1091/mbc.11.2.467</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Cheung</surname><given-names>AK</given-names></name><name><surname>Tomlinson</surname><given-names>RC</given-names></name><name><surname>Alcázar-Román</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>L</given-names></name><name><surname>Billich</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Klumpp</surname><given-names>M</given-names></name><name><surname>Rondeau</surname><given-names>JM</given-names></name><name><surname>Fazal</surname><given-names>AN</given-names></name><name><surname>Wilson</surname><given-names>CJ</given-names></name><name><surname>Myer</surname><given-names>V</given-names></name><name><surname>Joberty</surname><given-names>G</given-names></name><name><surname>Bouwmeester</surname><given-names>T</given-names></name><name><surname>Labow</surname><given-names>MA</given-names></name><name><surname>Finan</surname><given-names>PM</given-names></name><name><surname>Porter</surname><given-names>JA</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name><name><surname>Baird</surname><given-names>D</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name><name><surname>Tallarico</surname><given-names>JA</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling</article-title><source>Chemistry &amp; Biology</source><volume>20</volume><fpage>912</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2013.05.010</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campeau</surname><given-names>PM</given-names></name><name><surname>Lenk</surname><given-names>GM</given-names></name><name><surname>Lu</surname><given-names>JT</given-names></name><name><surname>Bae</surname><given-names>Y</given-names></name><name><surname>Burrage</surname><given-names>L</given-names></name><name><surname>Turnpenny</surname><given-names>P</given-names></name><name><surname>Román Corona-Rivera</surname><given-names>J</given-names></name><name><surname>Morandi</surname><given-names>L</given-names></name><name><surname>Mora</surname><given-names>M</given-names></name><name><surname>Reutter</surname><given-names>H</given-names></name><name><surname>Vulto-van Silfhout</surname><given-names>AT</given-names></name><name><surname>Faivre</surname><given-names>L</given-names></name><name><surname>Haan</surname><given-names>E</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name><name><surname>Lee</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Yunis-Varón syndrome is caused by mutations in FIG4, encoding a phosphoinositide phosphatase</article-title><source>American Journal of Human Genetics</source><volume>92</volume><fpage>781</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2013.03.020</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbajal</surname><given-names>KS</given-names></name><name><surname>Mironova</surname><given-names>Y</given-names></name><name><surname>Ulrich-Lewis</surname><given-names>JT</given-names></name><name><surname>Kulkarni</surname><given-names>D</given-names></name><name><surname>Grifka-Walk</surname><given-names>HM</given-names></name><name><surname>Huber</surname><given-names>AK</given-names></name><name><surname>Shrager</surname><given-names>P</given-names></name><name><surname>Giger</surname><given-names>RJ</given-names></name><name><surname>Segal</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis</article-title><source>Journal of Immunology</source><volume>195</volume><fpage>2552</fpage><lpage>2559</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1501097</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Westenbroek</surname><given-names>RE</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Edwards</surname><given-names>CA</given-names></name><name><surname>Sorenson</surname><given-names>DR</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>McEwen</surname><given-names>DP</given-names></name><name><surname>O'Malley</surname><given-names>HA</given-names></name><name><surname>Bharucha</surname><given-names>V</given-names></name><name><surname>Meadows</surname><given-names>LS</given-names></name><name><surname>Knudsen</surname><given-names>GA</given-names></name><name><surname>Vilaythong</surname><given-names>A</given-names></name><name><surname>Noebels</surname><given-names>JL</given-names></name><name><surname>Saunders</surname><given-names>TL</given-names></name><name><surname>Scheuer</surname><given-names>T</given-names></name><name><surname>Shrager</surname><given-names>P</given-names></name><name><surname>Catterall</surname><given-names>WA</given-names></name><name><surname>Isom</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mice lacking sodium channel beta1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>4030</fpage><lpage>4042</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4139-03.2004</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>CY</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Dowling</surname><given-names>JJ</given-names></name><name><surname>Jin</surname><given-names>N</given-names></name><name><surname>Adamska</surname><given-names>M</given-names></name><name><surname>Shiga</surname><given-names>K</given-names></name><name><surname>Szigeti</surname><given-names>K</given-names></name><name><surname>Shy</surname><given-names>ME</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Lupski</surname><given-names>JR</given-names></name><name><surname>Weisman</surname><given-names>LS</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J</article-title><source>Nature</source><volume>448</volume><fpage>68</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1038/nature05876</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coman</surname><given-names>I</given-names></name><name><surname>Barbin</surname><given-names>G</given-names></name><name><surname>Charles</surname><given-names>P</given-names></name><name><surname>Zalc</surname><given-names>B</given-names></name><name><surname>Lubetzki</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Axonal signals in central nervous system myelination, demyelination and remyelination</article-title><source>Journal of the Neurological Sciences</source><volume>233</volume><fpage>67</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2005.03.029</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessaud</surname><given-names>E</given-names></name><name><surname>Yang</surname><given-names>LL</given-names></name><name><surname>Hill</surname><given-names>K</given-names></name><name><surname>Cox</surname><given-names>B</given-names></name><name><surname>Ulloa</surname><given-names>F</given-names></name><name><surname>Ribeiro</surname><given-names>A</given-names></name><name><surname>Mynett</surname><given-names>A</given-names></name><name><surname>Novitch</surname><given-names>BG</given-names></name><name><surname>Briscoe</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Interpretation of the sonic hedgehog morphogen gradient by a temporal adaptation mechanism</article-title><source>Nature</source><volume>450</volume><fpage>717</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1038/nature06347</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>XP</given-names></name><name><surname>Shen</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Dawson</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Weisman</surname><given-names>LS</given-names></name><name><surname>Delling</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome</article-title><source>Nature Communications</source><volume>1</volume><fpage>38</fpage><pub-id pub-id-type="doi">10.1038/ncomms1037</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>SH</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Mironova</surname><given-names>Y</given-names></name><name><surname>Ming</surname><given-names>GL</given-names></name><name><surname>Kolodkin</surname><given-names>AL</given-names></name><name><surname>Giger</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Semaphorin 5A inhibits synaptogenesis in early postnatal- and adult-born hippocampal dentate granule cells</article-title><source>eLife</source><volume>3</volume><pub-id pub-id-type="doi">10.7554/eLife.04390</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egami</surname><given-names>Y</given-names></name><name><surname>Taguchi</surname><given-names>T</given-names></name><name><surname>Maekawa</surname><given-names>M</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name><name><surname>Araki</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Small GTPases and phosphoinositides in the regulatory mechanisms of macropinosome formation and maturation</article-title><source>Frontiers in Physiology</source><volume>5</volume><fpage>374</fpage><pub-id pub-id-type="doi">10.3389/fphys.2014.00374</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emery</surname><given-names>B</given-names></name><name><surname>Agalliu</surname><given-names>D</given-names></name><name><surname>Cahoy</surname><given-names>JD</given-names></name><name><surname>Watkins</surname><given-names>TA</given-names></name><name><surname>Dugas</surname><given-names>JC</given-names></name><name><surname>Mulinyawe</surname><given-names>SB</given-names></name><name><surname>Ibrahim</surname><given-names>A</given-names></name><name><surname>Ligon</surname><given-names>KL</given-names></name><name><surname>Rowitch</surname><given-names>DH</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination</article-title><source>Cell</source><volume>138</volume><fpage>172</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.04.031</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emery</surname><given-names>B</given-names></name><name><surname>Dugas</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Purification of oligodendrocyte lineage cells from mouse cortices by immunopanning</article-title><source>Cold Spring Harbor Protocols</source><volume>2013</volume><fpage>854</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1101/pdb.prot073973</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faust</surname><given-names>PL</given-names></name><name><surname>Kaye</surname><given-names>EM</given-names></name><name><surname>Powers</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Myelin lesions associated with lysosomal and peroxisomal disorders</article-title><source>Expert Review of Neurotherapeutics</source><volume>10</volume><fpage>1449</fpage><lpage>1466</lpage><pub-id pub-id-type="doi">10.1586/ern.10.127</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>CJ</given-names></name><name><surname>Lenk</surname><given-names>GM</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>4868</fpage><lpage>4878</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp460</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>CJ</given-names></name><name><surname>Lenk</surname><given-names>GM</given-names></name><name><surname>Jones</surname><given-names>JM</given-names></name><name><surname>Grant</surname><given-names>AE</given-names></name><name><surname>Winters</surname><given-names>JJ</given-names></name><name><surname>Dowling</surname><given-names>JJ</given-names></name><name><surname>Giger</surname><given-names>RJ</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neuronal expression of fig4 is both necessary and sufficient to prevent spongiform neurodegeneration</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>3525</fpage><lpage>3534</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds179</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fields</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>White matter in learning, cognition and psychiatric disorders</article-title><source>Trends in Neurosciences</source><volume>31</volume><fpage>361</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2008.04.001</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folkerth</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Abnormalities of developing white matter in lysosomal storage diseases</article-title><source>Journal of Neuropathology and Experimental Neurology</source><volume>58</volume><fpage>887</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1097/00005072-199909000-00001</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frühbeis</surname><given-names>C</given-names></name><name><surname>Fröhlich</surname><given-names>D</given-names></name><name><surname>Krämer-Albers</surname><given-names>EM</given-names></name><name><surname>Fruhbeis</surname><given-names>C</given-names></name><name><surname>Frohlich</surname><given-names>D</given-names></name><name><surname>Kramer-Albers</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Emerging roles of exosomes in neuron-glia communication</article-title><source>Frontiers in Physiology</source><volume>3</volume><fpage>119</fpage><pub-id pub-id-type="doi">10.3389/fphys.2012.00119</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grishchuk</surname><given-names>Y</given-names></name><name><surname>Sri</surname><given-names>S</given-names></name><name><surname>Rudinskiy</surname><given-names>N</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Stember</surname><given-names>KG</given-names></name><name><surname>Cottle</surname><given-names>MW</given-names></name><name><surname>Sapp</surname><given-names>E</given-names></name><name><surname>Difiglia</surname><given-names>M</given-names></name><name><surname>Muzikansky</surname><given-names>A</given-names></name><name><surname>Betensky</surname><given-names>RA</given-names></name><name><surname>Wong</surname><given-names>AM</given-names></name><name><surname>Bacskai</surname><given-names>BJ</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Kelleher</surname><given-names>RJ</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Slaugenhaupt</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV</article-title><source>Acta Neuropathologica Communications</source><volume>2</volume><fpage>133</fpage><pub-id pub-id-type="doi">10.1186/s40478-014-0133-7</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>I</given-names></name><name><surname>Munro</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>An N-terminally acetylated Arf-like GTPase is localised to lysosomes and affects their motility</article-title><source>Journal of Cell Science</source><volume>119</volume><fpage>1494</fpage><lpage>1503</lpage><pub-id pub-id-type="doi">10.1242/jcs.02958</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutagalung</surname><given-names>AH</given-names></name><name><surname>Novick</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Role of Rab GTPases in membrane traffic and cell physiology</article-title><source>Physiological Reviews</source><volume>91</volume><fpage>119</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1152/physrev.00059.2009</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikonomov</surname><given-names>OC</given-names></name><name><surname>Sbrissa</surname><given-names>D</given-names></name><name><surname>Delvecchio</surname><given-names>K</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>JP</given-names></name><name><surname>Rappolee</surname><given-names>D</given-names></name><name><surname>Shisheva</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The phosphoinositide kinase PIKfyve is vital in early embryonic development: preimplantation lethality of <sup>PIKfyve-/-</sup> embryos but normality of <sup>PIKfyve+/-</sup> mice</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>13404</fpage><lpage>13413</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.222364</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2</article-title><source>Neurogenetics</source><volume>6</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1007/s10048-004-0207-y</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>T</given-names></name><name><surname>Dakin</surname><given-names>KA</given-names></name><name><surname>Stevens</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>PR</given-names></name><name><surname>Kozlov</surname><given-names>SV</given-names></name><name><surname>Stewart</surname><given-names>CL</given-names></name><name><surname>Fields</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Astrocytes promote myelination in response to electrical impulses</article-title><source>Neuron</source><volume>49</volume><fpage>823</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2006.02.006</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jean</surname><given-names>S</given-names></name><name><surname>Kiger</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Coordination between RAB GTPase and phosphoinositide regulation and functions</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>13</volume><fpage>463</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1038/nrm3379</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jean</surname><given-names>S</given-names></name><name><surname>Cox</surname><given-names>S</given-names></name><name><surname>Nassari</surname><given-names>S</given-names></name><name><surname>Kiger</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Starvation-induced MTMR13 and RAB21 activity regulates VAMP8 to promote autophagosome-lysosome fusion</article-title><source>EMBO Reports</source><volume>16</volume><fpage>297</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.15252/embr.201439464</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>N</given-names></name><name><surname>Chow</surname><given-names>CY</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Zolov</surname><given-names>SN</given-names></name><name><surname>Bronson</surname><given-names>R</given-names></name><name><surname>Davisson</surname><given-names>M</given-names></name><name><surname>Petersen</surname><given-names>JL</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Duex</surname><given-names>JE</given-names></name><name><surname>Goldowitz</surname><given-names>D</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name><name><surname>Weisman</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P(2) in yeast and mouse</article-title><source>The EMBO Journal</source><volume>27</volume><fpage>3221</fpage><lpage>3234</lpage><pub-id pub-id-type="doi">10.1038/emboj.2008.248</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>SH</given-names></name><name><surname>Fukaya</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>JK</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Bergles</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration</article-title><source>Neuron</source><volume>68</volume><fpage>668</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.09.009</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karim</surname><given-names>SA</given-names></name><name><surname>Barrie</surname><given-names>JA</given-names></name><name><surname>McCulloch</surname><given-names>MC</given-names></name><name><surname>Montague</surname><given-names>P</given-names></name><name><surname>Edgar</surname><given-names>JM</given-names></name><name><surname>Kirkham</surname><given-names>D</given-names></name><name><surname>Anderson</surname><given-names>TJ</given-names></name><name><surname>Nave</surname><given-names>KA</given-names></name><name><surname>Griffiths</surname><given-names>IR</given-names></name><name><surname>McLaughlin</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease</article-title><source>Glia</source><volume>55</volume><fpage>341</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1002/glia.20465</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Raiker</surname><given-names>SJ</given-names></name><name><surname>Venkatesh</surname><given-names>K</given-names></name><name><surname>Geary</surname><given-names>R</given-names></name><name><surname>Robak</surname><given-names>LA</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yeh</surname><given-names>HH</given-names></name><name><surname>Shrager</surname><given-names>P</given-names></name><name><surname>Giger</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>2753</fpage><lpage>2765</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5586-07.2008</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenk</surname><given-names>GM</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mouse models of PI(3,5)P2 deficiency with impaired lysosome function</article-title><source>Methods in Enzymology</source><volume>534</volume><fpage>245</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-397926-1.00014-7</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>O</given-names></name><name><surname>Hoekstra</surname><given-names>D</given-names></name><name><surname>Baron</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Polarity development in oligodendrocytes: sorting and trafficking of myelin components</article-title><source>Journal of Molecular Neuroscience</source><volume>35</volume><fpage>35</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1007/s12031-007-9024-8</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makinodan</surname><given-names>M</given-names></name><name><surname>Rosen</surname><given-names>KM</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name><name><surname>Corfas</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A critical period for social experience-dependent oligodendrocyte maturation and myelination</article-title><source>Science</source><volume>337</volume><fpage>1357</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1126/science.1220845</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marinelli</surname><given-names>C</given-names></name><name><surname>Bertalot</surname><given-names>T</given-names></name><name><surname>Zusso</surname><given-names>M</given-names></name><name><surname>Skaper</surname><given-names>SD</given-names></name><name><surname>Giusti</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage</article-title><source>Frontiers in Cellular Neuroscience</source><volume>10</volume><fpage>27</fpage><pub-id pub-id-type="doi">10.3389/fncel.2016.00027</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masaki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Polarization and myelination in myelinating glia</article-title><source>ISRN Neurology</source><volume>2012</volume><fpage>769412</fpage><pub-id pub-id-type="doi">10.5402/2012/769412</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayinger</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Phosphoinositides and vesicular membrane traffic</article-title><source>Biochimica Et Biophysica Acta</source><volume>1821</volume><fpage>1104</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2012.01.002</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCartney</surname><given-names>AJ</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Weisman</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Phosphatidylinositol 3,5-bisphosphate: low abundance, high significance</article-title><source>BioEssays</source><volume>36</volume><fpage>52</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1002/bies.201300012</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuguchi</surname><given-names>R</given-names></name><name><surname>Sugimori</surname><given-names>M</given-names></name><name><surname>Takebayashi</surname><given-names>H</given-names></name><name><surname>Kosako</surname><given-names>H</given-names></name><name><surname>Nagao</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Nabeshima</surname><given-names>Y</given-names></name><name><surname>Shimamura</surname><given-names>K</given-names></name><name><surname>Nakafuku</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Combinatorial roles of olig2 and neurogenin2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons</article-title><source>Neuron</source><volume>31</volume><fpage>757</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00413-5</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>C</given-names></name><name><surname>Bauer</surname><given-names>NM</given-names></name><name><surname>Schäfer</surname><given-names>I</given-names></name><name><surname>White</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Making myelin basic protein -from mRNA transport to localized translation</article-title><source>Frontiers in Cellular Neuroscience</source><volume>7</volume><fpage>169</fpage><pub-id pub-id-type="doi">10.3389/fncel.2013.00169</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nave</surname><given-names>KA</given-names></name><name><surname>Trapp</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Axon-glial signaling and the glial support of axon function</article-title><source>Annual Review of Neuroscience</source><volume>31</volume><fpage>535</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.30.051606.094309</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>G</given-names></name><name><surname>Lenk</surname><given-names>GM</given-names></name><name><surname>Reddel</surname><given-names>SW</given-names></name><name><surname>Grant</surname><given-names>AE</given-names></name><name><surname>Towne</surname><given-names>CF</given-names></name><name><surname>Ferguson</surname><given-names>CJ</given-names></name><name><surname>Simpson</surname><given-names>E</given-names></name><name><surname>Scheuerle</surname><given-names>A</given-names></name><name><surname>Yasick</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>S</given-names></name><name><surname>Blouin</surname><given-names>R</given-names></name><name><surname>Brandt</surname><given-names>C</given-names></name><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Biesecker</surname><given-names>LG</given-names></name><name><surname>Batish</surname><given-names>SD</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P₂ phosphatase FIG4</article-title><source>Brain</source><volume>134</volume><fpage>1959</fpage><lpage>1971</lpage><pub-id pub-id-type="doi">10.1093/brain/awr148</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname><given-names>M</given-names></name><name><surname>Hiraoka</surname><given-names>Y</given-names></name><name><surname>Matsuoka</surname><given-names>T</given-names></name><name><surname>Tomimoto</surname><given-names>H</given-names></name><name><surname>Takao</surname><given-names>K</given-names></name><name><surname>Miyakawa</surname><given-names>T</given-names></name><name><surname>Oshima</surname><given-names>N</given-names></name><name><surname>Kiyonari</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Kita</surname><given-names>T</given-names></name><name><surname>Nishi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>1506</fpage><lpage>1513</lpage><pub-id pub-id-type="doi">10.1038/nn.2438</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>B</given-names></name><name><surname>Fromholt</surname><given-names>SE</given-names></name><name><surname>Hess</surname><given-names>EJ</given-names></name><name><surname>Crawford</surname><given-names>TO</given-names></name><name><surname>Griffin</surname><given-names>JW</given-names></name><name><surname>Sheikh</surname><given-names>KA</given-names></name><name><surname>Schnaar</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice</article-title><source>Experimental Neurology</source><volume>195</volume><fpage>208</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2005.04.017</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlman</surname><given-names>SJ</given-names></name><name><surname>Mar</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Leukodystrophies</article-title><source>Advances in Experimental Medicine and Biology</source><volume>724</volume><fpage>154</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1007/978-1-4614-0653-2_13</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prolo</surname><given-names>LM</given-names></name><name><surname>Vogel</surname><given-names>H</given-names></name><name><surname>Reimer</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The lysosomal sialic acid transporter sialin is required for normal CNS myelination</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>15355</fpage><lpage>15365</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3005-09.2009</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pusic</surname><given-names>AD</given-names></name><name><surname>Kraig</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination</article-title><source>Glia</source><volume>62</volume><fpage>284</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1002/glia.22606</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raiker</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Baldwin</surname><given-names>KT</given-names></name><name><surname>Duan</surname><given-names>Y</given-names></name><name><surname>Shrager</surname><given-names>P</given-names></name><name><surname>Giger</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>12432</fpage><lpage>12445</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0895-10.2010</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rempe</surname><given-names>D</given-names></name><name><surname>Vangeison</surname><given-names>G</given-names></name><name><surname>Hamilton</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Jepson</surname><given-names>M</given-names></name><name><surname>Federoff</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Synapsin I Cre transgene expression in male mice produces germline recombination in progeny</article-title><source>Genesis</source><volume>44</volume><fpage>44</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1002/gene.20183</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzer</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Polarized domains of myelinated axons</article-title><source>Neuron</source><volume>40</volume><fpage>297</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(03)00628-7</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schardt</surname><given-names>A</given-names></name><name><surname>Brinkmann</surname><given-names>BG</given-names></name><name><surname>Mitkovski</surname><given-names>M</given-names></name><name><surname>Sereda</surname><given-names>MW</given-names></name><name><surname>Werner</surname><given-names>HB</given-names></name><name><surname>Nave</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The SNARE protein SNAP-29 interacts with the GTPase Rab3A: Implications for membrane trafficking in myelinating glia</article-title><source>Journal of Neuroscience Research</source><volume>87</volume><fpage>3465</fpage><lpage>3479</lpage><pub-id pub-id-type="doi">10.1002/jnr.22005</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulze</surname><given-names>U</given-names></name><name><surname>Vollenbröker</surname><given-names>B</given-names></name><name><surname>Braun</surname><given-names>DA</given-names></name><name><surname>Van Le</surname><given-names>T</given-names></name><name><surname>Granado</surname><given-names>D</given-names></name><name><surname>Kremerskothen</surname><given-names>J</given-names></name><name><surname>Fränzel</surname><given-names>B</given-names></name><name><surname>Klosowski</surname><given-names>R</given-names></name><name><surname>Barth</surname><given-names>J</given-names></name><name><surname>Fufezan</surname><given-names>C</given-names></name><name><surname>Wolters</surname><given-names>DA</given-names></name><name><surname>Pavenstädt</surname><given-names>H</given-names></name><name><surname>Weide</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The Vac14-interaction network is linked to regulators of the endolysosomal and autophagic pathway</article-title><source>Molecular &amp; Cellular Proteomics : MCP</source><volume>13</volume><fpage>1397</fpage><lpage>1411</lpage><pub-id pub-id-type="doi">10.1074/mcp.M113.034108</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweitzer</surname><given-names>JK</given-names></name><name><surname>Krivda</surname><given-names>JP</given-names></name><name><surname>D'Souza-Schorey</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Neurodegeneration in Niemann-Pick Type C disease and Huntington's disease: impact of defects in membrane trafficking</article-title><source>Current Drug Targets</source><volume>10</volume><fpage>653</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.2174/138945009788680437</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schüller</surname><given-names>U</given-names></name><name><surname>Heine</surname><given-names>VM</given-names></name><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>Kho</surname><given-names>AT</given-names></name><name><surname>Dillon</surname><given-names>AK</given-names></name><name><surname>Han</surname><given-names>YG</given-names></name><name><surname>Huillard</surname><given-names>E</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Ligon</surname><given-names>AH</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name><name><surname>Rowitch</surname><given-names>DH</given-names></name><name><surname>Ligon</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma</article-title><source>Cancer Cell</source><volume>14</volume><fpage>123</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2008.07.005</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>M</given-names></name><name><surname>Trajkovic</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis</article-title><source>Journal of Cell Science</source><volume>119</volume><fpage>4381</fpage><lpage>4389</lpage><pub-id pub-id-type="doi">10.1242/jcs.03242</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>M</given-names></name><name><surname>Lyons</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Axonal selection and myelin sheath generation in the central nervous system</article-title><source>Current Opinion in Cell Biology</source><volume>25</volume><fpage>512</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2013.04.007</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenmark</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Rab GTPases as coordinators of vesicle traffic</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>10</volume><fpage>513</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1038/nrm2728</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toth</surname><given-names>AB</given-names></name><name><surname>Terauchi</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>LY</given-names></name><name><surname>Johnson-Venkatesh</surname><given-names>EM</given-names></name><name><surname>Larsen</surname><given-names>DJ</given-names></name><name><surname>Sutton</surname><given-names>MA</given-names></name><name><surname>Umemori</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Synapse maturation by activity-dependent ectodomain shedding of SIRPα</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>1417</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1038/nn.3516</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trajkovic</surname><given-names>K</given-names></name><name><surname>Dhaunchak</surname><given-names>AS</given-names></name><name><surname>Goncalves</surname><given-names>JT</given-names></name><name><surname>Wenzel</surname><given-names>D</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Bunt</surname><given-names>G</given-names></name><name><surname>Nave</surname><given-names>KA</given-names></name><name><surname>Simons</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Neuron to glia signaling triggers myelin membrane exocytosis from endosomal storage sites</article-title><source>The Journal of Cell Biology</source><volume>172</volume><fpage>937</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1083/jcb.200509022</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaccari</surname><given-names>I</given-names></name><name><surname>Carbone</surname><given-names>A</given-names></name><name><surname>Previtali</surname><given-names>SC</given-names></name><name><surname>Mironova</surname><given-names>YA</given-names></name><name><surname>Alberizzi</surname><given-names>V</given-names></name><name><surname>Noseda</surname><given-names>R</given-names></name><name><surname>Rivellini</surname><given-names>C</given-names></name><name><surname>Bianchi</surname><given-names>F</given-names></name><name><surname>Del Carro</surname><given-names>U</given-names></name><name><surname>D'Antonio</surname><given-names>M</given-names></name><name><surname>Lenk</surname><given-names>GM</given-names></name><name><surname>Wrabetz</surname><given-names>L</given-names></name><name><surname>Giger</surname><given-names>RJ</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name><name><surname>Bolino</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Loss of Fig4 in both Schwann cells and motor neurons contributes to CMT4J neuropathy</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>383</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu451</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>XP</given-names></name><name><surname>Samie</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Goschka</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Harlow</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>MX</given-names></name><name><surname>Clapham</surname><given-names>DE</given-names></name><name><surname>Ren</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>TPC proteins are phosphoinositide- activated sodium-selective ion channels in endosomes and lysosomes</article-title><source>Cell</source><volume>151</volume><fpage>372</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.08.036</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>TRPML1: an ion channel in the lysosome</article-title><source>Handbook of Experimental Pharmacology</source><volume>222</volume><fpage>631</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-54215-2_24</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>R</given-names></name><name><surname>Krämer-Albers</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Axon-glia interaction and membrane traffic in myelin formation</article-title><source>Frontiers in Cellular Neuroscience</source><volume>7</volume><fpage>284</fpage><pub-id pub-id-type="doi">10.3389/fncel.2013.00284</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winters</surname><given-names>JJ</given-names></name><name><surname>Ferguson</surname><given-names>CJ</given-names></name><name><surname>Lenk</surname><given-names>GM</given-names></name><name><surname>Giger-Mateeva</surname><given-names>VI</given-names></name><name><surname>Shrager</surname><given-names>P</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name><name><surname>Giger</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Congenital CNS hypomyelination in the Fig4 null mouse is rescued by neuronal expression of the PI(3,5)P(2) phosphatase Fig4</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>17736</fpage><lpage>17751</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1482-11.2011</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winterstein</surname><given-names>C</given-names></name><name><surname>Trotter</surname><given-names>J</given-names></name><name><surname>Krämer-Albers</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Distinct endocytic recycling of myelin proteins promotes oligodendroglial membrane remodeling</article-title><source>Journal of Cell Science</source><volume>121</volume><fpage>834</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1242/jcs.022731</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaghootfam</surname><given-names>A</given-names></name><name><surname>Gieselmann</surname><given-names>V</given-names></name><name><surname>Eckhardt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Delay of myelin formation in arylsulphatase A-deficient mice</article-title><source>The European Journal of Neuroscience</source><volume>21</volume><fpage>711</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.03891.x</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>D</given-names></name><name><surname>McGonigal</surname><given-names>R</given-names></name><name><surname>Barrie</surname><given-names>JA</given-names></name><name><surname>Cappell</surname><given-names>J</given-names></name><name><surname>Cunningham</surname><given-names>ME</given-names></name><name><surname>Meehan</surname><given-names>GR</given-names></name><name><surname>Fewou</surname><given-names>SN</given-names></name><name><surname>Edgar</surname><given-names>JM</given-names></name><name><surname>Rowan</surname><given-names>E</given-names></name><name><surname>Ohmi</surname><given-names>Y</given-names></name><name><surname>Furukawa</surname><given-names>K</given-names></name><name><surname>Furukawa</surname><given-names>K</given-names></name><name><surname>Brophy</surname><given-names>PJ</given-names></name><name><surname>Willison</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>880</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3996-13.2014</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Hoang</surname><given-names>T</given-names></name><name><surname>Montgomery</surname><given-names>RL</given-names></name><name><surname>Zhao</surname><given-names>XH</given-names></name><name><surname>Bu</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>van Es</surname><given-names>JH</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Hsieh</surname><given-names>J</given-names></name><name><surname>Bassel-Duby</surname><given-names>R</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name><name><surname>Lu</surname><given-names>QR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>829</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1038/nn.2333</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Lieberman</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin</article-title><source>PLoS Genetics</source><volume>9</volume><elocation-id>e1003462</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003462</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zolov</surname><given-names>SN</given-names></name><name><surname>Chow</surname><given-names>CY</given-names></name><name><surname>Slutsky</surname><given-names>SG</given-names></name><name><surname>Richardson</surname><given-names>SC</given-names></name><name><surname>Piper</surname><given-names>RC</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Nau</surname><given-names>JJ</given-names></name><name><surname>Westrick</surname><given-names>RJ</given-names></name><name><surname>Morrison</surname><given-names>SJ</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name><name><surname>Weisman</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>104</volume><fpage>17518</fpage><lpage>17523</lpage><pub-id pub-id-type="doi">10.1073/pnas.0702275104</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Sloan</surname><given-names>SA</given-names></name><name><surname>Bennett</surname><given-names>ML</given-names></name><name><surname>Scholze</surname><given-names>AR</given-names></name><name><surname>O'Keeffe</surname><given-names>S</given-names></name><name><surname>Phatnani</surname><given-names>HP</given-names></name><name><surname>Guarnieri</surname><given-names>P</given-names></name><name><surname>Caneda</surname><given-names>C</given-names></name><name><surname>Ruderisch</surname><given-names>N</given-names></name><name><surname>Deng</surname><given-names>S</given-names></name><name><surname>Liddelow</surname><given-names>SA</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Daneman</surname><given-names>R</given-names></name><name><surname>Maniatis</surname><given-names>T</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name><name><surname>Wu</surname><given-names>JQ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>11929</fpage><lpage>11947</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1860-14.2014</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Arpag</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Hamilton</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>YS</given-names></name><name><surname>Vanoye</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Reactivation of Lysosomal Ca2+ Efflux Rescues Abnormal Lysosomal Storage in FIG4-Deficient Cells</article-title><source>The Journal of Neuroscience</source><volume>35</volume><fpage>6801</fpage><lpage>6812</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4442-14.2015</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuchero</surname><given-names>JB</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Intrinsic and extrinsic control of oligodendrocyte development</article-title><source>Current Opinion in Neurobiology</source><volume>23</volume><fpage>914</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2013.06.005</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuchero</surname><given-names>JB</given-names></name><name><surname>Fu</surname><given-names>MM</given-names></name><name><surname>Sloan</surname><given-names>SA</given-names></name><name><surname>Ibrahim</surname><given-names>A</given-names></name><name><surname>Olson</surname><given-names>A</given-names></name><name><surname>Zaremba</surname><given-names>A</given-names></name><name><surname>Dugas</surname><given-names>JC</given-names></name><name><surname>Wienbar</surname><given-names>S</given-names></name><name><surname>Caprariello</surname><given-names>AV</given-names></name><name><surname>Kantor</surname><given-names>C</given-names></name><name><surname>Leonoudakis</surname><given-names>D</given-names></name><name><surname>Leonoudakus</surname><given-names>D</given-names></name><name><surname>Lariosa-Willingham</surname><given-names>K</given-names></name><name><surname>Kronenberg</surname><given-names>G</given-names></name><name><surname>Gertz</surname><given-names>K</given-names></name><name><surname>Soderling</surname><given-names>SH</given-names></name><name><surname>Miller</surname><given-names>RH</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CNS myelin wrapping is driven by actin disassembly</article-title><source>Developmental Cell</source><volume>34</volume><fpage>152</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.06.011</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>SH</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Stalker</surname><given-names>TJ</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>McKennan</surname><given-names>C</given-names></name><name><surname>Riese</surname><given-names>MJ</given-names></name><name><surname>Guzman</surname><given-names>JF</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Lian</surname><given-names>L</given-names></name><name><surname>Joshi</surname><given-names>R</given-names></name><name><surname>Meng</surname><given-names>R</given-names></name><name><surname>Seeholzer</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>JK</given-names></name><name><surname>Koretzky</surname><given-names>G</given-names></name><name><surname>Marks</surname><given-names>MS</given-names></name><name><surname>Abrams</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Loss of pikfyve in platelets causes a lysosomal disease leading to inflammation and thrombosis in mice</article-title><source>Nature Communications</source><volume>5</volume><fpage>4691</fpage><pub-id pub-id-type="doi">10.1038/ncomms5691</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.13023.029</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Barres</surname><given-names>Ben</given-names></name><aff id="aff11"><institution>Stanford School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your work entitled &quot;PI(3,5)P<sub>2</sub> Biosynthesis Regulates Oligodendrocyte Differentiation by Intrinsic and Extrinsic Mechanisms&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers and the evaluation has been overseen by a Reviewing Editor and Gary Westbrook as the Senior Editor.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>Here, the authors investigate trafficking mechanisms involving PI(3,5)P<sub>2</sub> in OLs and neurons and how this trafficking pathway regulates myelination. The starting point is that <italic>Fig4</italic>-deficient mice have profound hypomyelination and spongiform neuron degeneration. The authors further investigate the mechanisms of FIG4 function by generating mice lacking <italic>Fig4</italic> specifically in neuronal or oOLsodendrocyte lineages. They find the following major results: 1) loss of <italic>Fig4</italic> in OLs myelins OL maturation, widespread hypomyelination, and the aberrant trafficking of myelin proteins. In vitro large intracellular vesicles accumulate. 2) Loss of <italic>Fig4</italic> in neurons also causes hypomyelination, reduced OL maturation, but in addition it causes more severe neurodegeneration. As expected, phenotypic analysis of these mice shows hypomyelination by EM, reduced conduction velocities, etc. Overall, the data are interesting and sound. While the first half of the paper deals with the phenotypic analysis of the mice (in keeping with the previous publications), the second half of the paper really breaks new ground as the authors show that mice lacking PIKfyve enzymes or are mutant for <italic>Vac14</italic> also have similar hypomyelination and OL maturation defects. These experiments are very nice and provide additional confirmation of the importance of the Fig4/Vac14/PIKfyve enzyme complex for normal myelination. The authors then show the hypomyelination defects (not associated with OL maturation) may result from impaired trafficking of myelin proteins like MAG and PLP.</p><p>Essential revisions:</p><p>1) No g ratio analysis is shown to make it clear whether <italic>Fig4</italic> null oligodendrocytes form normal myelin sheath.</p><p>2) The paper demonstrates that absence of other components components of the <italic>Fig4</italic> complex, PIKFYVE and VAC14 may also lead to hypomyelination, although the data here are in a way premature and should include convincing morphological analysis.</p><p>3) Altogether, the data supports a role for the PI(3,5)P<sub>2</sub> biosynthesis complex in myelination by regulating membrane trafficking in oligodendrocytes, but additional experiments would make the story more convincing.</p><p>4) Although the discovery of the Fig4/Vac14/PIKfyve enzyme complex for normal myelination is significant, these results still don't tell us anything about the nature of what is being trafficked in neurons or immature OLs that leads to the hypomyelination phenotypes. Of course, this is very hard to do and will no doubt be the focus of the next paper.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.13023.030</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>Essential revisions:</italic></p><p><italic>1) No g ratio analysis is shown to make it clear whether Fig4 null oligodendrocytes form normal myelin sheath.</italic></p><p>We agree with the reviewers’ comment and have included g-ratio analysis for the <italic>Fig4</italic> conditional knock-out (cKO) mice lacking <italic>Fig4</italic> in neurons (<italic>SynCre</italic>) or in the OL lineage (<italic>Olig2Cre</italic>) mice. In both cKO mice, g ratios are increased, indicating that myelin sheath thickness is reduced. These data are now shown in <xref ref-type="fig" rid="fig2">Figure 2E</xref>.</p><p><italic>2) The paper demonstrates that absence of other components of the Fig4 complex, PIKFYVE and VAC14 may also lead to hypomyelination, although the data here are in a way premature and should include convincing morphological analysis.</italic></p><p>Morphological studies of epoxy resin embedded and toluidine blue stained optic nerve sections from P14 <italic>Pikfyve<sup>flox/flox</sup>, Olig2Cre</italic> mice (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>) and <italic>VAC14<sup>L156R/L156R</sup></italic> (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>) are now included in the manuscript. Loss of <italic>Pikfyve</italic> in the OL lineage leads to a complete loss of myelin. Consistent with electrophysiological and biochemical studies, toluidine blue labeling of <italic>VAC14<sup>L156R/L156R</sup></italic> optic nerve sections revealed severe hypomyelination.</p><p><italic>3) Altogether, the data supports a role for the PI(3,5)P2 biosynthesis complex in myelination by regulating membrane trafficking in oligodendrocytes, but additional experiments would make the story more convincing.</italic></p><p>We agree with the reviewers’ comment. In addition to the membrane trafficking studies in primary OLs, shown in <xref ref-type="fig" rid="fig8">Figures 8</xref> and <xref ref-type="fig" rid="fig9">9</xref> of the original submission, we now included OL membrane trafficking studies in acute forebrain tissue from P14 mice (<xref ref-type="fig" rid="fig10">Figure 10</xref> and <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1</xref>). We show that in acute wildtype brain slices (kept in oxygenated artificial cerebrospinal fluid) plasma membrane derived MAG is rapidly endocytosed and localized to small vesicular structures that accumulate in the cell soma and OL processes that form internodes. To visualize MAG trafficking, brain slices were incubated with mouse anti-MAG-Alexa555 antibody for two hours. To distinguish between surface-localized MAG and endocytosed MAG, brain slices were fixed and incubated with an anti-mouse Alexa488 secondary antibody under non-permabilizing conditions. As shown in <xref ref-type="fig" rid="fig10">Figure 10A-A</xref>”, the majority of MAG in wildtype slices is endocytosed and only labeled by anti-MAG-Alexa555. To demonstrate antibody specificity, parallel studies with <italic>Mag<sup>-/-</sup></italic>brain slices were carried out (<xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1D-E</xref>) and revealed no staining above background. To demonstrate anti-MAG-Alexa555 antibody is taken up by OLs, cells in the OL lineage were genetically labeled (<italic>LacZ/EGFP, Olig2Cre).</italic> Three-dimensional rendering of EGFP<sup>+</sup> cells (OLs) revealed accumulation of MAG in small intracellular vesicles (see Insert in <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1C</xref>). Thus far these experiments show that we can monitor MAG endocytosis and vesicular localization in acute brain slices of wildtype mice. To demonstrate a role for the lipid PI(3,5)P<sub>2</sub> in this process, experiments were repeated with acute brain slices from <italic>Pikfyve<sup>flox/flox</sup>, Olig2Cre</italic> mice. As shown in <xref ref-type="fig" rid="fig10">Figure 10B-B</xref>”, MAG trafficking is impaired. Endocytosis of MAG from the plasma membrane does occur in some cells (see insert in <xref ref-type="fig" rid="fig10">Figure 10B</xref>”), vesicle accumulation is perinuclear and no labeling of endocytosed MAG in cellular processes is observed. Together, these studies show that PI(3,5)P<sub>2</sub> plays a critical role in mobilization of plasma membrane derived MAG in brain slices.</p><p><italic>4) Although the discovery of the Fig4/Vac14/PIKfyve enzyme complex for normal myelination is significant, these results still don't tell us anything about the nature of what is being trafficked in neurons or immature OLs that leads to the hypomyelination phenotypes. Of course, this is very hard to do and will no doubt be the focus of the next paper.</italic></p><p>These are important questions and the focus of ongoing studies. In the revised manuscript we have added one additional piece of data. We now show that trafficking of MAG through LE/Lys is impaired, as plasma membrane derived MAG accumulates in large perinuclear vesicles in <italic>Fig4<sup>-/-</sup></italic>OLs. Trafficking of plasma membrane derived MOG occurs through recycling endosomes (RE) and is not affected by <italic>Fig4</italic> deficiency. This shows that PI(3,5)P<sub>2</sub> is required for membrane trafficking through the LE/Lys compartment but not through RE.</p></body></sub-article></article>